<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Behav Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Behav. Genet</journal-id>
<journal-title-group>
<journal-title>Behavior Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0001-8244</issn>
<issn pub-type="epub">1573-3297</issn>
<publisher>
<publisher-name>Springer US</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29882083</article-id>
<article-id pub-id-type="pmc">6028865</article-id>
<article-id pub-id-type="publisher-id">9902</article-id>
<article-id pub-id-type="doi">10.1007/s10519-018-9902-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>High Incidence of Copy Number Variants in Adults with Intellectual Disability and Co-morbid Psychiatric Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6018-3043</contrib-id>
<name>
<surname>Viñas-Jornet</surname>
<given-names>Marina</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Esteba-Castillo</surname>
<given-names>Susanna</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baena</surname>
<given-names>Neus</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ribas-Vidal</surname>
<given-names>Núria</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ruiz</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Torrents-Rodas</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gabau</surname>
<given-names>Elisabeth</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vilella</surname>
<given-names>Elisabet</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martorell</surname>
<given-names>Lourdes</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Armengol</surname>
<given-names>Lluís</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Novell</surname>
<given-names>Ramon</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Guitart</surname>
<given-names>Míriam</given-names>
</name>
<address>
<phone>+34 6933200</phone>
<email>mguitart@tauli.cat</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.7080.f</institution-id><institution>Genetics lab, UDIAT-centre diagnostic. Parc Taulí Hospital Universitari. Institut d’Investigació i Innovació Parc Taulí I3PT. Universitat Autònoma de Barcelona, </institution></institution-wrap>C/Parc Tauli,1, 08208 Sabadell, Barcelona Spain </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.7080.f</institution-id><institution>Cellular Biology, Physiology and Immunology Department, </institution><institution>Universitat Autònoma de Barcelona, </institution></institution-wrap>Bellaterra, Barcelona, Spain </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1762 1460</institution-id><institution-id institution-id-type="GRID">grid.425907.d</institution-id><institution>Mental Health and Intellectual Disability Specialized Service, </institution><institution>Institut Assistència Sanitària (IAS), Parc Hospitalari Martí i Julià, </institution></institution-wrap>Girona, Spain </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.7080.f</institution-id><institution>Pediatry-Clinical Genetics Service, </institution><institution>Parc Taulí Hospital Universitari. Institut d’Investigació i Innovació Parc Taulí I3PT. Universitat Autònoma de Barcelona, </institution></institution-wrap>Sabadell, Spain </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2284 9230</institution-id><institution-id institution-id-type="GRID">grid.410367.7</institution-id><institution>Hospital Universitari Institut Pere Mata, IISPV, Universitat Rovira i Virgili, CIBERSAM, </institution></institution-wrap>Reus, Spain </aff>
<aff id="Aff6"><label>6</label>Research and Development Department, qGenomics Laboratory, Barcelona, Spain </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>7</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>7</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<volume>48</volume>
<issue>4</issue>
<fpage>323</fpage>
<lpage>336</lpage>
<history>
<date date-type="received">
<day>9</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p>A genetic analysis of unexplained mild-moderate intellectual disability and co-morbid psychiatric or behavioural disorders is not systematically conducted in adults. A cohort of 100 adult patients affected by both phenotypes were analysed in order to identify the presence of copy number variants (CNVs) responsible for their condition identifying a yield of 12.8% of pathogenic CNVs (19% when including clinically recognizable microdeletion syndromes). Moreover, there is a detailed clinical description of an additional 11% of the patients harbouring possible pathogenic CNVs—including a 7q31 deletion (<italic>IMMP2L</italic>) in two unrelated patients and duplications in 3q29, 9p24.2p24.1 and 15q14q15.1—providing new evidence of its contribution to the phenotype. This study adds further proof of including chromosomal microarray analysis (CMA) as a mandatory test to improve the diagnosis in the adult patients in psychiatric services.</p>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1007/s10519-018-9902-6) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Adult patients</kwd>
<kwd>Behavioural disorders</kwd>
<kwd>Copy number variants</kwd>
<kwd>Intellectual disability</kwd>
<kwd>Psychiatric disorders</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004587</institution-id>
<institution>Instituto de Salud Carlos III</institution>
</institution-wrap>
</funding-source>
<award-id>PI080778</award-id>
<principal-award-recipient>
<name>
<surname>Guitart</surname>
<given-names>Míriam</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Fundació Parc Taulí - Insitut d’Investigació i Innovació Parc Taulí I3PT</institution>
</funding-source>
<award-id>CIR2009/33</award-id>
<principal-award-recipient>
<name>
<surname>Viñas-Jornet</surname>
<given-names>Marina</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Fundació Parc Taulí - Institut d’Investigació i Innovació Parc Taulí I3PT</institution>
</funding-source>
<award-id>CIR2010/034</award-id>
<principal-award-recipient>
<name>
<surname>Viñas-Jornet</surname>
<given-names>Marina</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Fundació Barnola-Vallribera</institution>
</funding-source>
<award-id>2011</award-id>
<principal-award-recipient>
<name>
<surname>Guitart</surname>
<given-names>Míriam</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Science+Business Media, LLC, part of Springer Nature 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p>Intellectual disability (ID) is a complex and multifactorial disorder that includes both intellectual and adaptive functioning deficits in the conceptual, social and practical domains with onset during the developmental period. This disorder affects approximately 1–3% of the general population, and between 10 and 40% of people with ID also present with mental illness or behavioural disorders (Cooper et al. <xref ref-type="bibr" rid="CR12">2007</xref>; Lowe et al. <xref ref-type="bibr" rid="CR44">2007</xref>; Morgan et al. <xref ref-type="bibr" rid="CR52">2008</xref>). The diagnostic categories of these mental disorders are based on the symptoms (Stein et al. <xref ref-type="bibr" rid="CR74">2013</xref>), but there is considerable clinical heterogeneity and overlap with different psychiatric categories (Burmeister et al. <xref ref-type="bibr" rid="CR8">2008</xref>). Indeed, the boundaries of the diagnostic categories can be blurred when the patients’ symptoms are not clearly expressed. The diagnosis of a psychiatric disorder in subjects with ID can be difficult, and most symptoms tend to be attributed to the ID. For this reason, the co-occurrence of both entities is usually overlooked (Costello and Bouras <xref ref-type="bibr" rid="CR13">2006</xref>).</p>
<p>Copy number variants (CNVs) are a source of human genetic variation and have been described as an important genomic cause of human disease (Iafrate et al. <xref ref-type="bibr" rid="CR35">2004</xref>; Sebat et al. <xref ref-type="bibr" rid="CR72">2004</xref>). Screening of ID patient cohorts via chromosomal microarray analysis (CMA) has led to the characterization of new syndromes, such as 8q21.11 deletion syndrome (OMIM: 614230) and 19p13.3 microdeletion/microduplication syndrome (Dolan et al. <xref ref-type="bibr" rid="CR17">2010</xref>; Orellana et al. <xref ref-type="bibr" rid="CR58">2015</xref>). Additionally, there is evidence that CNVs can predispose individuals to the development of psychiatric disorders, such as the autism spectrum disorders (ASDs) (Marshall et al. <xref ref-type="bibr" rid="CR48">2008</xref>; Hedges et al. <xref ref-type="bibr" rid="CR33">2012</xref>), schizophrenia (SQZ) (Kirov et al. <xref ref-type="bibr" rid="CR39">2012</xref>; Xu et al. <xref ref-type="bibr" rid="CR88">2008</xref>), bipolar disorder (Green et al. <xref ref-type="bibr" rid="CR30">2015</xref>) and attention-deficit/hyperactive disorder (ADHD) (Jarick et al. <xref ref-type="bibr" rid="CR36">2014</xref>; Ramos-Quiroga et al. <xref ref-type="bibr" rid="CR68">2014</xref>). Numerous CNV loci have been recurrently observed across ID and various neuropsychiatric phenotypes, such as the16p11.2 and <italic>NRXN1</italic> deletions, both of which are associated with ID, SQZ and ASD. These findings suggest that ID and psychiatric disorders may share genetic susceptibility factors (Guilmatre et al. <xref ref-type="bibr" rid="CR31">2009</xref>).</p>
<p>A large proportion of the adult population affected by ID lacks a genetic diagnosis. Some of these adult patients have never received a diagnostic assessment; alternatively, in some cases the assessment is completed without finding an explanation for the ID possibly due to the use of less advanced technologies than are currently available. At present, there is little knowledge of the genetics of ID and co-morbid psychiatric disorder in adults. Nevertheless, CMA and whole exome sequencing could shed light on the genetic diagnoses in adults with idiopathic ID (Baker et al. <xref ref-type="bibr" rid="CR3">2012</xref>; Posey et al. <xref ref-type="bibr" rid="CR66">2016</xref>; Taylor et al. <xref ref-type="bibr" rid="CR77">2010</xref>; Wolfe et al. <xref ref-type="bibr" rid="CR87">2016</xref>). Here, we report the genetic analysis of 100 adult patients affected by ID and psychiatric and/or behavioural disorders. The main purpose of this study is to investigate the contribution of putative pathogenic CNVs among patients with ID and comorbid psychiatric/behavioural disorders.</p>
</sec>
<sec id="Sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="Sec3">
<title>Participants</title>
<p>This study was designed prospectively. Cognitive, psychiatric and behavioural evaluation was performed by psychiatric specialists at the Mental Health ID Service (“Parc Hospitalari Martí i Julià”, Girona, Catalonia, Spain) while clinical-dysmorphic evaluation and genetic assessment was performed by a clinical geneticist at the Clinical Genetics Department (“Parc Taulí Hospital Universitari”, Sabadell, Catalonia, Spain). This study was approved by the institutional ethics committee (CEIC 2009/582). A legal guardian or family member that legally represented the participant signed the informed consent form. Adult patients over the age of 18 years were consecutively recruited using the following inclusion criteria: mild (IQ = 75 − 50) or moderate (IQ = 50 − 35) ID according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria and a defined psychiatric disorder or behavioural disorder according to the measures listed in Table <xref ref-type="table" rid="Tab1">1</xref>. The exclusion criteria were having severe ID or sensory impairment that precluded a proper examination, having suffered alterations in the central nervous system unrelated to the ID (i.e., head injury, stroke or brain tumours), the presence of untreated diseases with associated cognitive deficits (i.e., hypothyroidism, vitamin B12 deficiency or diabetes mellitus) and substance abuse. This recruitment led to 100 eligible patients for the analysis, including five sibling pairs and a sibling trio.</p>
<p>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Cognitive, psychiatric and behavioural measures tests</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Measures</th><th align="left">Tests</th></tr></thead><tbody><tr><td align="left">Cognitive</td><td align="left">– K-BIT-II (Kauffman Brief Intelligence Test-II)<break></break>– ABS-RC2 first part (Adaptive Behaviour Scale Residence Community-2)</td></tr><tr><td align="left">Psychiatric</td><td align="left">– PAS-ADD (Psychiatric Assessment for Adults with Developmental Disabilities)<break></break>– Compulsive behaviour checklist<break></break>– Y-BOCS (Yale-Brown Obsessive Compulsive Scale)<break></break>– RBQ (Repetitive Behaviour Questionnaire)<break></break>– NPI (Neuropsychiatric Inventory)</td></tr><tr><td align="left">Behavioural</td><td align="left">– ABC-ECA Scale (Aberrant Behaviour Checklist)<break></break>– ABS-RC2 second part (Adaptive Behaviour Scale Residence Community-2)</td></tr></tbody></table></table-wrap>
</p>
</sec>
<sec id="Sec4">
<title>Clinical evaluation: cognitive, behavioural, psychiatric and dysmorphic measures</title>
<p>Different tests were administered to all participants to identify the presence of ID and establish its severity level, as well as to identify the presence of a psychiatric and/or behavioural disorder (Table <xref ref-type="table" rid="Tab1">1</xref>). The presence of a behavioural disorder not necessarily related to a mental disorder was defined according to (Emerson <xref ref-type="bibr" rid="CR19">1995</xref>) as “culturally abnormal behaviour of such intensity, frequency or duration that the physical safety of the person or others is placed in serious jeopardy, or behaviour which is likely to seriously limit or deny them access to ordinary community facilities”. A family history of ID, psychiatric or behavioural disorders was also recorded.</p>
<p>Dysmorphic features were classified into five categories as follows: craniofacial, limbs, cutaneous, genital and body (all other dysmorphisms). A category was considered dysmorphic if at least one feature was abnormal.</p>
</sec>
<sec id="Sec5">
<title>Genetic analysis</title>
<p>The cohort was first analysed by G-banded karyotyping to determine the presence of unbalanced and balanced rearrangements. <italic>FMR1</italic> screening and other specific molecular technologies were applied to subjects who were clinically suspected of having a syndrome.</p>
<p>The CMA analysis was performed with the 400K Agilent platform (Agilent Technologies, Santa Cruz, CA, USA) on all patients without a clinically recognized syndrome (including subjects known to possess a chromosomal rearrangement). This oligonucleotide-based comparative genomic hybridization array covered the entire genome with an average resolution of 5.3 kb. The microarrays were processed according to the manufacturer’s specifications, and the Agilent Workbench 5.0, Feature Extraction and Cytogenomics softwares (Agilent Technologies, Santa Cruz, CA, USA) were used to render the image analysis with the manufacturer’s recommended settings and human genome assembly hg19. We called CNVs when there were at least five consecutive probes with a minimum log<sub>2</sub> ratio of ± 0.25.This low rate is capable to detect mosaicisms and using five consecutive probes avoid false positives.</p>
<p>The identified CNVs were cross-referenced with the Database of Genomic Variants (DGV, <ext-link ext-link-type="uri" xlink:href="http://projects.tcag.ca/variation">http://projects.tcag.ca/variation</ext-link>); those variants completely overlapped with common CNVs (prevalence &gt; 1% in the general population) were excluded from further analysis. All rare CNVs (prevalence &lt; 1% in the general population) were interpreted individually by comparing each genomic region to information available in public databases [University of California, Santa Cruz Genome Browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu">http://genome.ucsc.edu</ext-link>), National Center for Biotechnology Information (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>), Ensembl (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/index.html">http://www.ensembl.org/index.html</ext-link>), Decipher (<ext-link ext-link-type="uri" xlink:href="https://decipher.sanger.ac.uk/">https://decipher.sanger.ac.uk/</ext-link>), Clinical Genome Resource (<ext-link ext-link-type="uri" xlink:href="https://www.clinicalgenome.org">https://www.clinicalgenome.org</ext-link>)] and Online Mendelian Inheritance in Man database (<ext-link ext-link-type="uri" xlink:href="https://www.omim.org/">https://www.omim.org/</ext-link>) as well as literature, and classified into four categories as follows: (1) Pathogenic CNVs (pCNV), which overlap with known causative findings previously associated with ID or psychiatric disorders (from databases and literature). (2) Variants of unknown significance (VOUS) that were likely pathogenic (pVOUS) when at least two of the following conditions are met: (a) Partially overlap with a pathogenic susceptibility <italic>locus</italic>; (b) It is not reported in control population from (Coe et al. <xref ref-type="bibr" rid="CR11">2014</xref>); (c) Include genes enriched for deletions/duplications at nominal level of significance according to (Coe et al. <xref ref-type="bibr" rid="CR11">2014</xref>); (d) Include developmental delay (DD) genes from (Deciphering Developmental Disorders Study <xref ref-type="bibr" rid="CR14">2017</xref>); (e) Include genes with relevant function in the nervous system. (3) VOUS that were likely benign (bVOUS), which included only intronic regions of genes with a function in the nervous system not yet described in the patients or CNVs that included genes with unknown functions or functions not related to the central nervous system. (4) Benign CNVs (bCNVs), which were without genes or devoid of known regulatory elements. We focused on pCNVs and pVOUSs, both of which are likely associated with the affected phenotype. Customized multiplex ligation-dependent probe amplification (MLPA) and fluorescent in situ hybridization (FISH) were performed according to standard protocols to validate and determine the inheritance of CNVs. Custom MLPA probes were designed according to protocols and guidelines from MRC-Holland (Amsterdam, the Netherlands) and the ProSeek web server created by Estivill et al. (Pantano et al. <xref ref-type="bibr" rid="CR61">2008</xref>), and specific bacterial artificial chromosome clones were selected for the aberration regions.</p>
<p>Finally, since the cohort of 100 patients results from a 50-patient set which was subsequently increased with a second 50-patient set, we selected seven CNVs (pCNVs and pVOUS) identified in the first patient-set analysed by CMA to evaluate their recurrence. Two pCNVs associated with ID and psychiatric disorders (2p16.3 and 12p12.1) and five pVOUSs (2p12, 3q29, 15q14q15, 15q26.2 and 17q24) were analysed in a new set of 161 adult patients affected by mild/moderate ID and 189 controls using a custom MLPA.</p>
</sec>
<sec id="Sec6">
<title>Data analysis</title>
<p>The potential associations between categorical variables were tested using the <italic>χ</italic><sup><italic>2</italic></sup> test. When one or more of the expected values for the <italic>χ</italic><sup><italic>2</italic></sup> computation was lower than 5, the <italic>p</italic> value was computed using Fisher’s exact test. When a result was significant, the odds ratio was indicated as a measure of the effect size. The Kruskal–Wallis and Mann–Whitney <italic>U</italic> tests were performed for dependent continuous variables that showed non-normal distributions (as determined by the Shapiro–Wilk test and visual inspection). A threshold of p &lt; 0.05 was set to indicate statistical significance, and the Bonferroni correction was applied for post hoc comparisons. The statistical analyses were performed using the Statistical Package for Social Sciences (SPSS for Windows, Version 16.0., SPSS Inc., Chicago, IL, USA).</p>
</sec>
</sec>
<sec id="Sec7" sec-type="results">
<title>Results</title>
<sec id="Sec8">
<title>Description of the patient cohort</title>
<p>A patient cohort of 100 adults affected by ID and co-morbid psychiatric/behavioural disorders without a genetic diagnosis was recruited with the main purpose of identifying CNVs responsible for their conditions. The cohort comprised 50 men and 50 women with an average age of 31.28 years (18–56 years, SD = 10.14), of whom 60% had mild ID and 40% had moderate ID. Out of the 100 patients, 50 had both a psychiatric and a behavioural disorder, 37 had only a psychiatric disorder and 13 had only a behavioural disorder. Sixteen patients had a diagnosis of two different psychiatric disorders, nine of whom also presented with a behavioural disorder. Table <xref ref-type="table" rid="Tab2">2</xref> shows the distribution of the psychiatric disorders in our cohort according to ID severity level and the presence or absence of behavioural disorders. The <italic>χ</italic><sup><italic>2</italic></sup> test did not show a significant difference in the presence of psychiatric or behavioural disorders between the mild and moderate ID groups. Mild dysmorphic features were present in all patients and were identified via minor facial or cranial dysmorphologies (98%) and abnormalities in the limbs (44%), cutaneous tissue (52), genitals (16%) and other (60%).</p>
<p>
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Distribution of the psychiatric disorders according to the ID severity level and the presence or absence of behavioural disorders</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Psychiatric disorders (n = 116)*</th><th align="left">Mild ID</th><th align="left">Moderate ID</th></tr></thead><tbody><tr><td align="left">With behavioural disorders</td><td align="left">n = 36</td><td align="left">n = 36</td></tr><tr><td align="left"> Organic mental disorders (F01–F09)</td><td align="left">2 (5.6%)</td><td align="left">0</td></tr><tr><td align="left"> Schizophrenia spectrum (F20–F29)</td><td align="left">3 (8.3%)</td><td align="left">1 (2.8%)</td></tr><tr><td align="left"> Depressive disorders (F30–F39)</td><td align="left">3 (8.3%)</td><td align="left">0</td></tr><tr><td align="left"> Anxiety (F40–F48)</td><td align="left">14 (38.9%)</td><td align="left">12 (33.3%)</td></tr><tr><td align="left"> Non-organic disorder of the sleep-wake schedule (F51.2)</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left"> Personality disorders (F60–F69)</td><td align="left">7 (19.4%)</td><td align="left">3 (8.3%)</td></tr><tr><td align="left"> Psychological developmental disorders (F80–F89)</td><td align="left">0</td><td align="left">3 (8.3%)</td></tr><tr><td align="left"> Childhood behavioural/emotional disorders (F90–F98)</td><td align="left">3 (8.3%)</td><td align="left">8 (22.2%)</td></tr><tr><td align="left"> No diagnosable disorder</td><td align="left">4 (11.1%)</td><td align="left">9 (25%)</td></tr><tr><td align="left">Without behavioural disorders</td><td align="left">n = 33</td><td align="left">n = 11</td></tr><tr><td align="left"> Organic mental disorders (F01–F09)</td><td align="left">0</td><td align="left">0</td></tr><tr><td align="left"> Schizophrenia spectrum (F20–F29)</td><td align="left">5 (15.2%)</td><td align="left">3 (27.3%)</td></tr><tr><td align="left"> Depressive disorders (F30–F39)</td><td align="left">7 (21.2%)</td><td align="left">1 (9.1%)</td></tr><tr><td align="left"> Anxiety (F40–F48)</td><td align="left">15 (45.5%)</td><td align="left">2 (18.2%)</td></tr><tr><td align="left"> Non-organic disorder of the sleep-wake schedule (F51.2)</td><td align="left">0</td><td align="left">1 (9.1%)</td></tr><tr><td align="left"> Personality disorders (F60–F69)</td><td align="left">1 (3%)</td><td align="left">0</td></tr><tr><td align="left"> Psychological developmental disorders (F80–F89)</td><td align="left">3 (9.1%)</td><td align="left">3 (27.3%)</td></tr><tr><td align="left"> Childhood behavioural/emotional disorders (F90–F98)</td><td align="left">2 (6.1%)</td><td align="left">1 (9.1%)</td></tr><tr><td align="left"> No diagnosable disorder</td><td align="left">0</td><td align="left">0</td></tr></tbody></table><table-wrap-foot><p>*The table includes the 116 psychiatric diagnoses identified in the adult cohort (n): 36 in patients with mild ID and behaviour disorders; 36 in patients with moderate ID and behaviour disorders; 33 in patients with mild ID without behavioural disorders; 11 in patients with moderate ID without behavioural disorders. There were 16 individuals with two different psychiatric disorders</p></table-wrap-foot></table-wrap>
</p>
</sec>
<sec id="Sec9">
<title>Genetic analysis of the patient cohort</title>
<p>A preliminary karyotype identified four rearrangements and the specific molecular technologies confirmed the presence of a clinically recognized syndromes in fourteen individuals (Table <xref ref-type="table" rid="Tab3">3</xref>). The CMA performed in the 86 patients with no clinically recognized syndromes identified a total of 216 rare CNVs (additional file 1) with an average of 2.5 CNVs/patient and range of 0–8 CNVs/patient. According to the classification criteria, 13 pCNVs were the genetic cause of the phenotype and 11 pVOUSs were the putative cause of the phenotype (additional file 2) while 192 CNVs (88.9%) were non-pathogenic (139bVOUSs and 53 bCNVs). The 13pCNVs, nine deletions and four duplications, were identified in 11 of the 86 patients (12.8%) (Table <xref ref-type="table" rid="Tab4">4</xref>), given that two patients presented two CNVs—in one case the 2 pCNVs arose from a maternal inversion (patient 10) and in the other case the 2 pCNVs derived from an unbalanced translocation (patient 26) according to the FISH performed afterwards. The 11pVOUS, five deletions and six duplications, were identified in 11 of the 86 patients (12.8%) (Table <xref ref-type="table" rid="Tab4">4</xref>), but if we consider only one patient of each sibling set (given that we include four set of siblings in the CMA population), pVOUS are the putative cause of disease in nine of 82 patients (11%). The analysis of parental samples (when available) revealed that the pCNVs were de novo in seven patients and maternally inherited in two cases (one X-linked). In contrast, of the eight cases with pVOUSs with available parental samples, there were no de novo pVOUSs (Table <xref ref-type="table" rid="Tab4">4</xref>).</p>
<p>
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Well-known specific syndromes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Syndrome</th><th align="left">Genetic cause</th><th align="left">No. cases</th></tr></thead><tbody><tr><td align="left">Fragile X</td><td align="left">CGG expansion</td><td align="char" char=".">5</td></tr><tr><td align="left">Velocardiofacial</td><td align="left">22q11.2 deletion</td><td align="char" char=".">4</td></tr><tr><td align="left">Prader Willi</td><td align="left">15q11q13 deletion</td><td align="char" char=".">2</td></tr><tr><td align="left" rowspan="2">Smith Magenis</td><td align="left"><italic>RAI1</italic> point muation</td><td align="char" char=".">1</td></tr><tr><td align="left">17p11.2 deletion</td><td align="char" char=".">1</td></tr><tr><td align="left">Williams</td><td align="left">7q11.23 deletion</td><td align="char" char=".">1</td></tr></tbody></table></table-wrap>
</p>
<p>
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Phenotypic and genotypic description of patients with pathogenic and likely pathogenic CNVs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Pat Id</th><th align="left" colspan="2">ID</th><th align="left">Psychiatric disorder</th><th align="left" colspan="2">Behavioural disorder</th><th align="left">Dysmorphology</th><th align="left" colspan="2">FHD</th><th align="left">ISCN 2016</th><th align="left">CNV size (kb)</th><th align="left">RefSeq genes</th></tr></thead><tbody><tr><td align="left" colspan="12">Pathogenic CNVs (pCNV)</td></tr><tr><td align="left"> 55 ♀</td><td align="left" colspan="2">Mild</td><td align="left">BD</td><td align="left" colspan="2">NP</td><td align="left" colspan="2">Hypotelorism, high and narrow palate</td><td align="left">+</td><td align="left">arr[hg19] 2p16.3(50660882–51078593)x1 dn</td><td align="left">417</td><td align="left">
<italic>NRXN1</italic>
</td></tr><tr><td align="left"> 94 ♂</td><td align="left" colspan="2">Mild</td><td align="left">Persistent delusional disorders</td><td align="left" colspan="2">Verbally aggressive, physically aggressive and destructive behaviours</td><td align="left" colspan="2">Long face, wide forehead, long philtrum, high and narrow palate</td><td align="left">+</td><td align="left">arr[hg19] 2p16.3(50510602–51137271)x1 mat</td><td align="left">626</td><td align="left">
<italic>NRXN1</italic>
</td></tr><tr><td align="left"> 90 ♂</td><td align="left" colspan="2">Mod</td><td align="left">Specific (isolated) phobias; Adjustment disorders with mixed disturbance or emotions and conduct</td><td align="left" colspan="2">Verbally aggressive, oppositional, demanding and other problem behaviours</td><td align="left" colspan="2">Brachycephaly, long face, synophrys, blepharophimosis, downslanted palpebral fissures, short ears, prognathism, kyphosis, absent distal interphalangeal creases, generalized hirsutism</td><td align="left">+</td><td align="left">arr[hg19] 9q31.1q32(107056010–115867141)x1</td><td align="left">8,811</td><td align="left">67</td></tr><tr><td align="left" rowspan="2"> 26 ♂</td><td align="left" colspan="2" rowspan="2">Mod</td><td align="left" rowspan="2">OCD<break></break>ADHD</td><td align="left" colspan="2" rowspan="2">Physically aggressive behaviour</td><td align="left" colspan="2" rowspan="2">Long face, strabismus, broad nasal tip, dysplastic ears, high and narrow palate, widely-spaced nipples</td><td align="left" rowspan="2">–</td><td align="left">arr[hg19] 10q26.12q26.3(122259702–135434178)x1 der</td><td align="left">13,174</td><td align="left">113</td></tr><tr><td align="left">arr[hg19] 15q26.3(99168589–102480888)x3 der</td><td align="left">3,312</td><td align="left">32</td></tr><tr><td align="left"> 63 ♀</td><td align="left" colspan="2">Mild</td><td align="left">NP</td><td align="left" colspan="2">General diagnostic criteria for problem behaviour</td><td align="left" colspan="2">Narrow nasal bridge, broad nasal tip, high and narrow palate, retrognathia, generalized hirsutism</td><td align="left">–</td><td align="left">arr[hg19] 12p12.1(23432294–26233996)x1 dn</td><td align="left">2,801</td><td align="left">14<break></break>(<italic>SOX5</italic>)</td></tr><tr><td align="left"> 98 ♂</td><td align="left" colspan="2">Mild</td><td align="left">Specific (isolated) phobias</td><td align="left" colspan="2">Physically aggressive behaviour</td><td align="left" colspan="2">Macrocephaly, strabismus, high and narrow palate</td><td align="left">–</td><td align="left">arr[hg19] 15q11q13(23,699,701–29,006,852)x3 dn</td><td align="left">5,306</td><td align="left">126</td></tr><tr><td align="left"> 14 ♂</td><td align="left" colspan="2">Mild</td><td align="left">Generalized anxiety disorder</td><td align="left" colspan="2">NP</td><td align="left" colspan="2">High and narrow palate, dental malocclusion, obesity, gynecomastia, generalized hirsutism, macroorchidism</td><td align="left">+</td><td align="left">arr[hg19] 15q13.2q13.3(30943703–32439084)x1 dn</td><td align="left">1,495</td><td align="left">10<break></break>(<italic>CHRNA7</italic>)</td></tr><tr><td align="left"> 9 ♀</td><td align="left" colspan="2">Mod</td><td align="left">Acute polymorphic psychotic disorder without symptoms of schizophrenia</td><td align="left" colspan="2">NP</td><td align="left" colspan="2">Microcephaly, low posterior hairline, strabismus, small nose, wide nasal base, prognathism, short stature, scoliosis, nasal voice</td><td align="left">–</td><td align="left">arr[hg19] 16p12p11.2(18901309–29182196)x1 dn <sup>(a)</sup></td><td align="left">10,280</td><td align="left">131</td></tr><tr><td align="left"> 18 ♀</td><td align="left" colspan="2">Mod</td><td align="left">Childhood ASD</td><td align="left" colspan="2">Physically aggressive, destructive, oppositional and other problem behaviours</td><td align="left" colspan="2">Puffy eyelids, broad nasal bridge, downslanted palpebral fissures, high and narrow palate</td><td align="left">–</td><td align="left">arr[hg19] 22q13.33(51123291–51224402)x1 dn</td><td align="left">101</td><td align="left">4<break></break>(<italic>SHANK3</italic>)</td></tr><tr><td align="left"> 71 ♂</td><td align="left" colspan="2">Mild</td><td align="left">Other organic personality and behavioural disorders</td><td align="left" colspan="2">Verbally aggressive, physically aggressive and oppositional behaviours</td><td align="left" colspan="2">Round face, thick lower lip vermilion, dental malocclusion, obesity, flat feet</td><td align="left">+</td><td align="left">arr[hg19] Xp24.3p11.4(25816432–38085678)x2 mat <sup>(b)</sup></td><td align="left">12,244</td><td align="left">38</td></tr><tr><td align="left" rowspan="2"> 10 ♀</td><td align="left" colspan="2" rowspan="2">Mod</td><td align="left" rowspan="2">NP</td><td align="left" colspan="2" rowspan="2">Physically aggressive and oppositional behaviours</td><td align="left" colspan="2" rowspan="2">Macrocephaly, long face, wide nasal base, broad philtrum, macrostomia, high and narrow palate, gingival overgrowth, Sydney crease, camptodactyly, abnormal labia, capillary hemangioma</td><td align="left" rowspan="2">+</td><td align="left">arr[hg19] Xp22.33p11.2(169901-51101339)x3 mat inv <sup>(c)</sup></td><td align="left">51,008</td><td align="left">360</td></tr><tr><td align="left">arr[hg19] Xq25q28(124,642,297–155,227,312)x1 mat inv <sup>(c)</sup></td><td align="left">30,410</td><td align="left">335</td></tr><tr><td align="left" colspan="12">VOUS likely pathogenic (pVOUS)</td></tr><tr><td align="left"> 34 ♂</td><td align="left" colspan="2">Mild</td><td align="left">Post-traumatic stress disorder</td><td align="left" colspan="2">Verbally aggressive, physically aggressive and wandering behaviours</td><td align="left" colspan="2">Epicanthus, strabismus, thin upper lip, high and narrow palate, dental malocclusion, obesity, gynecomastia</td><td align="left">+</td><td align="left">arr[hg19] 3q29(196,022,728–196,515,371)x4 mat-pat</td><td align="left">492</td><td align="left">14</td></tr><tr><td align="left"> 32 ♂</td><td align="left" colspan="2">Mod</td><td align="left">Post-traumatic stress disorder</td><td align="left" colspan="2">NP</td><td align="left" colspan="2">Turricephaly, long face, accessory nipples</td><td align="left">+</td><td align="left">arr[hg19] 7q31.1(111198987–111280493)x1 mat</td><td align="left">81</td><td align="left">
<italic>IMMP2L</italic>
</td></tr><tr><td align="left"> 151 ♂</td><td align="left" colspan="2">Mod</td><td align="left">OCD; Childhood ASD</td><td align="left" colspan="2">Verbally aggressive and physically aggressive behaviours</td><td align="left" colspan="2">Sloping forehead, strabismus, fullness of upper eyelid, bilateral preauricular pit, protruding ears and underdeveloped crus of the helix, wide nasal base, everted lower lip vermilion, widely spaced teeth, cryptorchidism</td><td align="left">+</td><td align="left">arr[hg19] 7q31.1(111112186–111255558)x1 mat</td><td align="left">143</td><td align="left">
<italic>IMMP2L</italic>
</td></tr><tr><td align="left"> 66 ♂</td><td align="left" colspan="2">Mild</td><td align="left">Specific (isolated) phobias; Generalized anxiety disorder</td><td align="left" colspan="2">NP</td><td align="left" colspan="2">Long face, synophrys, hypotelorism, thin upper lip, broad jaw and prognathism</td><td align="left">+</td><td align="left">arr[hg19] 8q21.13(80288192–81019201)x1 pat</td><td align="left">731</td><td align="left">6</td></tr><tr><td align="left"> 85 ♂</td><td align="left" colspan="2">Mild</td><td align="left">Dual-role Transvestism</td><td align="left" colspan="2">Verbally aggressive, destructive, sexually inappropriate, oppositional, demanding and other problem behaviours</td><td align="left" colspan="2">Microcephaly, long face, narrow forehead, Low hanging columella, dental malocclusion, small testes</td><td align="left">–</td><td align="left">arr[hg19] 8p23.1(10254051–10449952)x1</td><td align="left">195</td><td align="left">3</td></tr><tr><td align="left"> 122 ♂ <sup>(*)</sup></td><td align="left" colspan="2">Mod</td><td align="left">NP</td><td align="left" colspan="2">Verbally aggressive behaviour</td><td align="left" colspan="2">Ptosis, long and protruding ears, broad and bifid nasal tip, large tongue, pectus excavatum, macroorchidism</td><td align="left">+</td><td align="left">arr[hg19] 9p24.2p24.1(4094627–4671089)x3</td><td align="left">576</td><td align="left">4</td></tr><tr><td align="left"> 123 ♂ <sup>(*)</sup></td><td align="left" colspan="2">Mod</td><td align="left">Generalized anxiety disorder</td><td align="left" colspan="2">Verbally aggressive and physically aggressive behaviours</td><td align="left" colspan="2">Macrocephaly, long face, broad forehead and metopic depression, protruding and low-set ears, long philtrum, thin upper lip, high and narrow palate</td><td align="left">+</td><td align="left">arr[hg19] 9p24.2p24.1(4094627–4671089)x3</td><td align="left">576</td><td align="left">4</td></tr><tr><td align="left"> 59 ♀ <sup>(#)</sup></td><td align="left" colspan="2">Mod</td><td align="left">ADHD</td><td align="left" colspan="2">Verbally aggressive, physically aggressive, destructive, oppositional, demanding and wandering behaviours</td><td align="left" colspan="2">Long face, hypotelorism, epicanthus, ptosis, broad jaw, long fingers</td><td align="left">+</td><td align="left">arr[hg19] 15q14q15.1(37882913–40621860)x3 pat</td><td align="left">2,738</td><td align="left">20<break></break>(<italic>SPRED1</italic>)</td></tr><tr><td align="left"> 60 ♂ <sup>(#)</sup></td><td align="left" colspan="2">Mod</td><td align="left">OCD; ADHD</td><td align="left" colspan="2">Sexually inappropriate, demanding and wandering behaviours</td><td align="left" colspan="2">Microcephaly, hypotelorism, long face, ptosis, broad jaw, long fingers, tall stature, pectus excavatum, numerous pigmented freckles</td><td align="left">+</td><td align="left">arr[hg19] 15q14q15.1(37882913–40621860)x3 pat</td><td align="left">2,738</td><td align="left">20<break></break>(<italic>SPRED1</italic>)</td></tr><tr><td align="left"> 92 ♂</td><td align="left" colspan="2">Mild</td><td align="left">Asperger’s Syndrome; Moderate depressive episode</td><td align="left" colspan="2">NP</td><td align="left" colspan="2">High and narrow palate</td><td align="left">+</td><td align="left">arr[hg19] 15q26.2(94959126–94983622)x1 pat</td><td align="left">24</td><td align="left">
<italic>MCTP2</italic>
</td></tr><tr><td align="left"> 79 ♂</td><td align="left" colspan="2">Mild</td><td align="left">Acute stress reaction; Other habit and impulse disorders</td><td align="left" colspan="2">Physically aggressive behaviour</td><td align="left" colspan="2">Long face, long ears and large earlobe, thin upper lip vermilion, exaggerated cupid’s bow, high and narrow palate</td><td align="left">+</td><td align="left">arr[hg19] 17q24.1q24.2(64129644–64759936)x3 pat</td><td align="left">630</td><td align="left">4</td></tr></tbody></table><table-wrap-foot><p><italic>CNV</italic> copy number variant, <italic>Pat Id</italic> patient identification; <italic>ID</italic> intellectual disability, <italic>Mod</italic> moderate, <italic>BD</italic> bipolar disorder, <italic>OCD</italic> obsessive–compulsive disorder, <italic>ADHD</italic> attention-deficit and hyperactive disorder, <italic>ASD</italic> autism spectrum disorder, <italic>NP</italic> not present, <italic>FHD</italic> familial history of psychiatric disorders; (+) Yes; (−) No; (mat inv) CNV derive from a maternal inversion; (der) derivative from a balanced translocation; (m‘at-pat) Inherited from both parents; (a) CNV identified by G-banded karyotype: 46,XX, del16p11.2p12; (b) CNV identified by G-banded karyotype: 46,XY,dup(X)(p11.4p24.3); (c) CNV identified by G-banded karyotype: 46,XX,der(X)inv(X)(p11.2q25),dup(X)(p11.2p22.33),del(X)(q25q28). (*) Siblings. (#) Siblings</p></table-wrap-foot></table-wrap>
</p>
<p>Two shared CNV regions were present in unrelated patients. The first CNV region was the pathogenic 2p16.3 deletion in patients 55 and 94, which partially included the <italic>NRXN1</italic> gene (Table <xref ref-type="table" rid="Tab4">4</xref>). The shared phenotype between these patients and the neuropsychological evaluation of deletion family carriers was previously reported (Vinas-Jornet et al. <xref ref-type="bibr" rid="CR79">2014</xref>). The second shared CNV was a 7q31.1 deletion that disrupted the <italic>IMMP2L</italic> gene, which encodes a catalytic subunit of the mitochondrial inner membrane peptidase (IMP) complex. This CNV was identified in two males (patients 32 and 151 from Table <xref ref-type="table" rid="Tab4">4</xref>) affected by moderate ID and psychiatric disorders [a post-traumatic stress disorder in one patient and obsessive–compulsive disorder (OCD) with childhood autism in the other patient]. The deletion was maternally inherited in these two unrelated patients, and both patients had a registered familial history: patient 32’s mother was diagnosed with early Alzheimer’s disease and patient 151’s maternal aunt was diagnosed with a psychiatric disorder.</p>
<p>Family studies may help to understand the pathogenicity of CNVs and delineate genotype-phenotype correlations. Of the five sibling pairs included in the cohort, we identified a putative genetic cause that was shared between siblings in two pairs. A 9p24.2p24.1 duplication was identified in two brothers affected by moderate ID and behavioural disorders (patients 122 and 123), but a generalized anxiety disorder was diagnosed in only one patient (Table <xref ref-type="table" rid="Tab4">4</xref>). This duplication overlaps two duplications described in DECIPHER in patients affected by cognitive and behavioural disorders (295,026 and 254,714, respectively). The second sibling pair was a female and her brother (patients 59 and 60) who were both affected by moderate ID, hyperkinetic conduct disorder and minor facial/cranial dysmorphology; the siblings shared a 2.7 Mb duplication in 15q14q15.1 (Table <xref ref-type="table" rid="Tab4">4</xref>). There are overlapping duplications in public databases (ClinVar) with unknown clinical significance in patients with global developmental delay (nssv580863 and nssv1609978), the first of whom also presented with microcephaly and upslanted palpebral fissures.</p>
<p>Finally, a homozygous 3q29 duplication was identified in patient 34, who was affected by mild ID, post-traumatic stress disorder and behavioural disorders (Table <xref ref-type="table" rid="Tab4">4</xref>). The patient was the third child of a consanguineous couple; both parents had borderline IQs and a heterozygous 3q29 duplication. The patient had a younger brother with a severe ID and ASD phenotype who also presented with the duplication in homozygosity.</p>
</sec>
<sec id="Sec10">
<title>Effect of CNVs on dysmorphic and neurodevelopmental traits</title>
<p>Demographic and clinical variables (gender, ID severity level, dysmorphology, psychiatric disorders, behavioural disorders and psychiatric co-morbidity) from the group of patients with an identified putative genetic cause (pCNV and pVOUS) were compared to the patients with an unknown possibly genetic cause (bVOUS, bCNVs and absence of rare CNVs). The comparison of the number of dysmorphic features, the ID severity level, psychiatric disorders or behavioural disorders between the two groups did not show any significant difference. Interestingly, the odds of having two psychiatric disorders diagnosed in the same patient were 4.22 times higher in the genetic cause group than in the unknown possible genetic cause group (95% CI 1.21–14.74, <italic>χ</italic><sup><italic>2</italic></sup> (1) = 5.56, p = 0.035).</p>
</sec>
<sec id="Sec11">
<title>Analysis of specific CNVs in an additional cohort</title>
<p>In order to evaluate the recurrence of seven pCNVs/pVOUS, an independent population of 161 patients affected by mild/moderate ID and 189 controls were analysed. None of the selected seven CNVs were detected either in the patients or the control individuals indicating a very low frequency of these pCNVs/pVOUS.</p>
</sec>
</sec>
<sec id="Sec12" sec-type="discussion">
<title>Discussion</title>
<p>A genetic cause of the ID and psychiatric phenotypes was identified in 25 patients of our adult cohort. This incidence is due to the diagnosis of clinically recognized syndromes such as fragile X, Velocardiofacial, Prader Willi, Smith Magenis and Williams not recognised at the adult psychiatric service. The application of CMA test in those patients without a recognised syndrome allows the genetic diagnosis in 12.8% in agreement to a similar adult population affected by ID and co-morbid psychiatric disorders (Wolfe et al. <xref ref-type="bibr" rid="CR87">2016</xref>). This rate would have increased to 19% if the CMA had been performed in all patients being comparable to an adult population with ID and mild-severe congenital malformation anomalies (Ho et al. <xref ref-type="bibr" rid="CR34">2016</xref>).</p>
<p>Interestingly, in our series we found a <italic>NRXN1</italic> deletion in two cases responsible for bipolar disorder, persistent delusional disorders and behavioural phenotype (Vinas-Jornet et al. <xref ref-type="bibr" rid="CR79">2014</xref>) in keeping with (Lowther et al. <xref ref-type="bibr" rid="CR45">2017</xref>).</p>
<p>An additional 11% of the patients present pVOUS that may contribute to the phenotype despite there not being strong evidence for their pathogenicity. Given the low frequency of each individual CNV it is important to report them to increase the knowledge and clarify their possible association with the phenotype.</p>
<p>The 7q31 deletion identified in two unrelated patients (Table <xref ref-type="table" rid="Tab4">4</xref>) disrupted the <italic>IMMP2L</italic> gene (NM_001244606). Although deletions in this region are reported as benign loss in ISCA database and are identified in control population, they are considered rare CNVs because their frequency is lower than 1% considering the DGV Gold Standard Variants (additional file 3). The 7q31 deletion was considered a risk factor in several neuropsychiatric disorders, including ASD (Maestrini et al. <xref ref-type="bibr" rid="CR47">2010</xref>; Pagnamenta et al. <xref ref-type="bibr" rid="CR60">2010</xref>; Casey et al. <xref ref-type="bibr" rid="CR10">2012</xref>), ADHD (Elia et al. <xref ref-type="bibr" rid="CR18">2010</xref>) and language disorder (Lai et al. <xref ref-type="bibr" rid="CR40">2001</xref>) and partial deletions of the <italic>IMMP2L</italic> gene in particular has been described as risk factors for neurological diseases with an incomplete penetrance (Gimelli et al. <xref ref-type="bibr" rid="CR24">2014</xref>). The history of Alzheimer’s disease in the carrier mother is interesting, particularly because the <italic>IMMP2L</italic> gene encodes a mitochondrial protein that regulates the levels of reactive oxygen species (George et al. <xref ref-type="bibr" rid="CR22">2011</xref>), and has been implicated in Alzheimer’s disease susceptibility (Swaminathan et al. <xref ref-type="bibr" rid="CR75">2012</xref>). This evidence suggests that <italic>IMMP2L</italic> may contribute to the ID and psychiatric disorders in these patients.</p>
<p>Little is known about the clinical effects of duplications in 3q29, 9p24.2p24.1 and 15q14q15.1 in contrast to the deletions in these regions that have been previously associated with neurodevelopmental disorders (Myles-Worsley et al. <xref ref-type="bibr" rid="CR53">2013</xref>; Bianchi et al. <xref ref-type="bibr" rid="CR6">2014</xref>; Spencer et al. <xref ref-type="bibr" rid="CR73">2011</xref>; Willatt et al. <xref ref-type="bibr" rid="CR85">2005</xref>). However, patients presented here suggest that these duplications could be pathogenic. The 3q29 duplication not only could disrupt the <italic>PAK2</italic> gene, which codifies a serine/threonine protein kinase involved in the dendritic development of early cortical neurons, but also includes the <italic>FBXO45</italic> gene. This gene, which is a component of an E3 ubiquitin ligase complex, is evolutionarily conserved and selectively expressed in the nervous system, plays an important role in the regulation of neurotransmission (Tada et al. <xref ref-type="bibr" rid="CR76">2010</xref>) and has been described as a candidate gene for SQZ (Wang et al. <xref ref-type="bibr" rid="CR82">2014</xref>). This CNV partially overlaps the 3.5 Mb critical region in 3q29 present in five members of a family affected by ID and microcephaly (Lisi et al. <xref ref-type="bibr" rid="CR43">2008</xref>) and spans some smaller duplications described in patients affected by ID and a wide range of minor dysmorphic features (Ballif et al. <xref ref-type="bibr" rid="CR4">2008</xref>). In our case, phenotypic severity correlated with the copy number of the 3q29 region in the proband, who harbours four copies of the 3q29 material and was affected by ID and a psychiatric disorder, and the parents, both of whom harbour three copies of 3q29 and had borderline IQs. A second putative pathogenic duplication identified in our cohort is located in 9p24.2p24.1 and includes the <italic>SLC1A1</italic> gene. This gene encodes a member of the high-affinity glutamate transporters, which are crucial for the termination of the postsynaptic action of the neurotransmitter glutamate and maintenance of extracellular glutamate concentrations below the neurotoxic levels. Changes in its expression are associated with neuropsychiatric diseases, such as OCD and SQZ (Porton et al. <xref ref-type="bibr" rid="CR65">2013</xref>; Bauer et al. <xref ref-type="bibr" rid="CR5">2008</xref>), and overexpression of <italic>SLC1A1</italic> has been demonstrated to increase the expression level of the two glial members of the glutamate transporter family (<italic>SLC1A2</italic> and <italic>SLC1A3</italic>), which are associated with SQZ (Afshari et al. <xref ref-type="bibr" rid="CR1">2015</xref>). Finally, although pathogenicity of the 15q14q15.1 duplication has not been demonstrated, this duplication includes three genes (<italic>SPRED1, RASGRP1</italic> and <italic>PAK6</italic>) that have been previously related to neuropsychiatric diseases (Brems et al. <xref ref-type="bibr" rid="CR7">2007</xref>; Denayer et al. <xref ref-type="bibr" rid="CR15">2008</xref>; Kato et al. <xref ref-type="bibr" rid="CR38">2011</xref>; Furnari et al. <xref ref-type="bibr" rid="CR20">2013</xref>). The presence of <italic>SPRED1</italic> is particularly interesting given that deletions and point mutations in this gene are responsible for Legius syndrome, which is a genetic skin pigmentation disorder that is sometimes accompanied by other common manifestations, including moderate ID, ADHD, hypotelorism and <italic>pectus excavatum</italic>; these symptoms were present in the two patients with the 15q14q15.1 duplication. This evidence suggests that the <italic>SPRED1</italic> gene may be responsible for the ID and neuropsychiatric disorders in our patients and that increased dosage in this region is capable of yielding a similar phenotype as decreased dosage.</p>
<p>Of the 13pCNVs and 11 pVOUSs, ten genes (<italic>NRXN1, IMMP2L, MSRA, SLC1A1, SOX5, UBE3A, CHRNA7, SPRED1, PRKCA</italic>, and <italic>SHANK3</italic>) have each been associated with more than one psychiatric phenotype (Table <xref ref-type="table" rid="Tab5">5</xref>) and neurodevelopmental disorders based on the hypothesis that perturbation of the same molecular pathway can result in different psychiatric diagnoses (Plummer et al. <xref ref-type="bibr" rid="CR64">2016</xref>); for instance, <italic>SHANK3</italic> and <italic>SLC1A1</italic> participate in the glutamatergic pathway and <italic>UBE3A</italic> and <italic>FBXO45</italic> in the ubiquitin pathway (Javitt <xref ref-type="bibr" rid="CR37">2007</xref>, Tebartz van Elst et al. <xref ref-type="bibr" rid="CR78">2014</xref>; Glessner et al. <xref ref-type="bibr" rid="CR28">2009</xref>; Plummer et al. <xref ref-type="bibr" rid="CR64">2016</xref>). Other genes involved in synaptic formation and function may contribute to behaviour impairments and a brain malfunction (Mehregan et al. <xref ref-type="bibr" rid="CR49">2016</xref>). Interestingly, we found that the presence of two psychiatric disorders increases the likelihood of detecting a pathogenic or possibly pathogenic CNV supporting the fact that different psychiatric disorders share common genetic aetiologies (Moreno-De-Luca et al. <xref ref-type="bibr" rid="CR51">2013</xref>).</p>
<p>
<table-wrap id="Tab5"><label>Table 5</label><caption><p>Genes associated with various psychiatric disorders</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Gene</th><th align="left" rowspan="2">Loci</th><th align="left" rowspan="2">Psychiatric disorder in current study</th><th align="left" colspan="7">Bibliography*</th></tr><tr><th align="left">ASD</th><th align="left">ADHD</th><th align="left">SQZ</th><th align="left">BD</th><th align="left">OCD</th><th align="left">A</th><th align="left">GTS</th></tr></thead><tbody><tr><td align="left" rowspan="4">
<italic>NRXN1</italic>
</td><td align="left" rowspan="4">2p16.3</td><td align="left">BD</td><td align="left" rowspan="4">+</td><td align="left" rowspan="4">+</td><td align="left" rowspan="4">+</td><td align="left" rowspan="4">+</td><td align="left" rowspan="4">–</td><td align="left" rowspan="4">+</td><td align="left" rowspan="4">+</td></tr><tr><td align="left">Delusional disorder</td></tr><tr><td align="left">Disexecutive syndrome</td></tr><tr><td align="left">Anxiety</td></tr><tr><td align="left" rowspan="3">
<italic>IMMP2L</italic>
</td><td align="left" rowspan="3">7q31</td><td align="left">GTS</td><td align="left" rowspan="3">+</td><td align="left" rowspan="3">+</td><td align="left" rowspan="3">–</td><td align="left" rowspan="3">+</td><td align="left" rowspan="3">+</td><td align="left" rowspan="3">–</td><td align="left" rowspan="3">+</td></tr><tr><td align="left">Post-traumatic stress disorder</td></tr><tr><td align="left">OCD + autism</td></tr><tr><td align="left">
<italic>MSRA</italic>
</td><td align="left">8p23.1</td><td align="left">Transvestism, destructive and aggressive behaviour</td><td align="left">–</td><td align="left">–</td><td align="left">+</td><td align="left">+</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">
<italic>SLC1A1</italic>
</td><td align="left">9p24.2p24.1</td><td align="left">Generalized anxiety disorder</td><td align="left">–</td><td align="left">–</td><td align="left">+</td><td align="left">+</td><td align="left">+</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left">
<italic>SOX5</italic>
</td><td align="left">12p12</td><td align="left">Behavioural disorder</td><td align="left">+</td><td align="left">+</td><td align="left">–</td><td align="left">–</td><td align="left">–</td><td align="left">+</td><td align="left">–</td></tr><tr><td align="left">
<italic>UBE3A</italic>
</td><td align="left">15q11q13</td><td align="left">Specific phobias</td><td align="left">+</td><td align="left">+</td><td align="left">+</td><td align="left">–</td><td align="left">+</td><td align="left">+</td><td align="left">–</td></tr><tr><td align="left">
<italic>CHRNA7</italic>
</td><td align="left">15q13.3</td><td align="left">Generalized anxiety disorder</td><td align="left">+</td><td align="left">+</td><td align="left">+</td><td align="left">+</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr><tr><td align="left" rowspan="2">
<italic>SPRED1</italic>
</td><td align="left" rowspan="2">15q14q15</td><td align="left">OCD</td><td align="left" rowspan="2">+</td><td align="left" rowspan="2">+</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td></tr><tr><td align="left">Hyperkinetic disorder</td></tr><tr><td align="left" rowspan="2">
<italic>RASGRP1</italic>
</td><td align="left" rowspan="2">15q14q15</td><td align="left">OCD</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">+</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td></tr><tr><td align="left">Hyperkinetic disorder</td></tr><tr><td align="left" rowspan="2">
<italic>MCTP2</italic>
</td><td align="left" rowspan="2">15q26.2</td><td align="left">Asperger syndrome</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">+</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td></tr><tr><td align="left">Depressive episode with somatic syndrome</td></tr><tr><td align="left" rowspan="2">
<italic>PRKCA</italic>
</td><td align="left" rowspan="2">17q24.1q24.2</td><td align="left">Acute stress reaction</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">+</td><td align="left" rowspan="2">+</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2">–</td><td align="left" rowspan="2"></td></tr><tr><td align="left">Other habit and impulse disorders</td></tr><tr><td align="left">
<italic>SHANK3</italic>
</td><td align="left">22q13.33</td><td align="left">Autism</td><td align="left">+</td><td align="left">–</td><td align="left">+</td><td align="left">+</td><td align="left">–</td><td align="left">–</td><td align="left">–</td></tr></tbody></table><table-wrap-foot><p><italic>ASD</italic> autism spectrum disorder, <italic>ADHD</italic> attention deficit and hyperactive disorder, <italic>SQZ</italic> schizophrenia, <italic>BD</italic> bipolar disorder, <italic>OCD</italic> obsessive–compulsive disorder, <italic>A</italic> anxiety, <italic>GTS</italic> Gilles de la Tourette syndrome</p><p>*Hahn and Friedman (<xref ref-type="bibr" rid="CR32">1999</xref>); Lai et al. (<xref ref-type="bibr" rid="CR40">2001</xref>); Ophoff et al. (<xref ref-type="bibr" rid="CR57">2002</xref>); Moessner et al. (<xref ref-type="bibr" rid="CR50">2007</xref>); Bauer et al. (<xref ref-type="bibr" rid="CR5">2008</xref>); Djurovic et al. (<xref ref-type="bibr" rid="CR16">2009</xref>); Pasmant et al. (<xref ref-type="bibr" rid="CR62">2009</xref>); Walss-Bass et al. (<xref ref-type="bibr" rid="CR81">2009</xref>); Wang et al. (<xref ref-type="bibr" rid="CR83">2009</xref>); Weiss et al. (<xref ref-type="bibr" rid="CR84">2009</xref>); Carroll et al. (<xref ref-type="bibr" rid="CR9">2010</xref>); Elia et al. (<xref ref-type="bibr" rid="CR18">2010</xref>); Gauthier et al. (<xref ref-type="bibr" rid="CR21">2010</xref>); Maestrini et al. (<xref ref-type="bibr" rid="CR47">2010</xref>); Pagnamenta et al. (<xref ref-type="bibr" rid="CR60">2010</xref>); Rosenfeld et al. (<xref ref-type="bibr" rid="CR69">2010</xref>); Wisniowiecka-Kowalnik et al. (<xref ref-type="bibr" rid="CR86">2010</xref>); Girirajan et al. (<xref ref-type="bibr" rid="CR25">2011</xref>); Kato et al. (<xref ref-type="bibr" rid="CR38">2011</xref>); Levy et al. (<xref ref-type="bibr" rid="CR42">2011</xref>); Ma et al. (<xref ref-type="bibr" rid="CR46">2011</xref>); Spencer et al. (<xref ref-type="bibr" rid="CR73">2011</xref>); Waga et al. (<xref ref-type="bibr" rid="CR80">2011</xref>); Casey et al. (<xref ref-type="bibr" rid="CR10">2012</xref>); Girirajan et al. (<xref ref-type="bibr" rid="CR27">2012</xref>); Lamb et al. (<xref ref-type="bibr" rid="CR41">2012</xref>); O’Roak et al. (<xref ref-type="bibr" rid="CR59">2012</xref>); Prasad et al. (<xref ref-type="bibr" rid="CR67">2012</xref>); Schaaf et al. (<xref ref-type="bibr" rid="CR71">2012</xref>); Grayton et al. (<xref ref-type="bibr" rid="CR29">2013</xref>); Myles-Worsley et al. (<xref ref-type="bibr" rid="CR53">2013</xref>); Porton et al. (<xref ref-type="bibr" rid="CR65">2013</xref>); Bacchelli et al. (<xref ref-type="bibr" rid="CR2">2014</xref>); Gimelli et al. (<xref ref-type="bibr" rid="CR24">2014</xref>); Noor et al. (<xref ref-type="bibr" rid="CR56">2014</xref>); Schaaf (<xref ref-type="bibr" rid="CR70">2014</xref>); Gillentine and Schaaf (<xref ref-type="bibr" rid="CR23">2015</xref>); Nesbitt et al. (<xref ref-type="bibr" rid="CR54">2015</xref>); Noor et al. (<xref ref-type="bibr" rid="CR55">2015</xref>)</p></table-wrap-foot></table-wrap>
</p>
<p>Our cohort has been clinically examined in great detail for psychiatric and behavioural disorders as well as a dysmorphological evaluation was performed by a clinical geneticist. Almost all patients in our cohort present mild cranial or facial dysmorphic features suggesting that having multiple mild dysmorphic features may be a clue to an underlying genetic cause, despite specific comparison was not possible. We suggest that adults with mild or moderate ID, psychiatric/behavioural disorders and mild dysmorphic signs are an especially CNV enriched group as shown in the present study.</p>
<p>We highlight there is a high familial burden of ID and neuropsychiatric disorders in all individuals with an inherited genetic cause mainly gathered in the pVOUS group. Inherited variants must be taken into account because they can act as susceptibility factors having an additive or synergistic effect (Pinto et al. <xref ref-type="bibr" rid="CR63">2010</xref>; Girirajan and Eichler <xref ref-type="bibr" rid="CR26">2010</xref>). The identification of a familial history in individuals with ID and neuropsychiatric disorders is challenging due to the continuous spectrum of the phenotype that could explain the discrepancy between family members. Therefore, pVOUS should be considered in larger studies to reinforce their pathogenicity for ID and co-morbid psychiatric disorders.</p>
<p>The data provided here from an adult cohort with mild-moderate ID and co-morbid psychiatric and behavioural disorders is essential to advance our knowledge of these pathologies and useful for genotype-phenotype correlations as well as contribute to the prognosis of the behavioural phenotype in children and adolescents with the same diagnoses. Most behaviours and organic/mental health problems are easier to work with and to understand when an aetiological diagnosis is delivered, which enables the planning of better medical intervention strategies. Furthermore, having a genetic diagnosis provides relevant information for families in terms of genetic counselling, allows improved care of all family members and provides an early diagnosis of related diseases, which is a significant issue to take into account when governments and authorities plan local and national health strategies. We propose that CMA testing together with a clinical genetics assessment would help to achieve more aetiological diagnoses in adult patients with ID and psychiatric disorders.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec13">
<p>Below is the link to the electronic supplementary material.</p>
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="10519_2018_9902_MOESM1_ESM.xlsx"><caption><p>Additional file 1 Rare CNVs identified in the adult population affected by intellectual disability and co-morbid psychiatric/behavioural disorders. (Pat Id) Patient identification; (CNV, ISCN 2016) Copy number variant according to the International System for Human Cytogenetic Nomenclature edited in 2016; (bp) Base pair; (MAT) Maternal; (PAT) Paternal; (MAT and PAT) Inherited from both progenitors; (CGHa) Comparative genomic hybridization array; (BAC FISH) Bacterial artificial chromosome clones for fluorescent in situ hybridization; (MLPA) Multiplex ligation-dependent probe amplification; (MLPA autism) MRC-Holland Probemix P343; (MLPA subtel) MRC-Holland Probemix P036 and P070; (MS-MLPA) Methylation-specific MLPA with MRC-Holland Probemix ME028; (NA) Not analysed; (*) Polymorphic variant reported here due to its putative clinical relevance; (NP) Not present (XLSX 64 KB)</p></caption></media></supplementary-material>
</p>
<p>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="10519_2018_9902_MOESM2_ESM.xlsx"><caption><p>Additional file 2 Pathogenic CNVs and variants of unknown significance (VOUS) likely pathogenic (pVOUS): summary of data from literature (Coe et al., 2014 and DDD 2017) as well as public databases. (Pat Id) Patient identification; (chr) chromosome; (bp) base pair; (ISCN 2016) International System for Human Cytogenetic Nomenclature edited in 2016; (CNV) Copy number variant; (DD) Developmental delay (XLSX 34 KB)</p></caption></media></supplementary-material>
</p>
<p>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="10519_2018_9902_MOESM3_ESM.xlsx"><caption><p>Additional file 3 7q31 copy number variants reported in Database of Genomic Variants. (DGV) Database of Genomic Variants; (CNVR) Copy number variant region; (bp) base pair (XLSX 12 KB)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p>Edited by Michael Lyons.</p>
</fn>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>The online version of this article (10.1007/s10519-018-9902-6) contains supplementary material, which is available to authorized users.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>Financial support was received from the “Instituto de Salud Carlos III” (FIS, grant no. PI080778), “Fundació Parc Taulí–Institut d’Investigació i Innovació Parc Taulí I3PT” (Grant Nos. CIR2009/33, CIR2010/034) and “Fundació Barnola-Vallribera 2011”. We acknowledge the following individuals for their help with this study: MC Mata, MC Dominguez, A Veraguas, M Garcia, O Villa and C Hernando. Finally, we especially thank the patients and families who participated in this study.</p>
</ack>
<notes notes-type="COI-statement">
<title>Compliance with ethical standards</title>
<sec id="FPar1">
<title>Conflict of interest</title>
<p>Marina Viñas-Jornet, Susanna Esteba-Castillo, Neus Baena, Núria Ribas-Vidal, Anna Ruiz, David Torrents-Rodas, Elisabeth Gabau, Elisabet Vilella, Lourdes Martorell, Lluís Armengol, Ramon Novell and Míriam Guitart declare that they have no conflict of interest.</p>
</sec>
<sec id="FPar2">
<title>Ethical Approval</title>
<p>All procedures performed in this study were in accordance with the ethical standards of the institutional ethics committee (CEIC 2009/582) of the Parc Taulí Hospital Universitari and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.</p>
</sec>
<sec id="d29e2679">
<title>Animal Rights</title>
<p>This article does not contain any studies with animals performed by any of the authors.</p>
</sec>
<sec id="d29e2684">
<title>Informed Consent</title>
<p>Informed written consent was obtained from all individual participants included in the study.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Afshari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Myles-Worsley</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>OS</given-names>
</name>
<name>
<surname>Tiobech</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Byerley</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Middleton</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Characterization of a novel mutation in SLC1A1 associated with schizophrenia</article-title>
<source/>Mol Neuropsychiatr
          <year>2015</year>
<volume>1</volume>
<fpage>125</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1159/000433599</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bacchelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ceroni</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lomartire</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Giannandrea</surname>
<given-names>M</given-names>
</name>
<name>
<surname>D’Adamo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bonora</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Parchi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tancredi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maestrini</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>A CTNNA3 compound heterozygous deletion implicates a role for alphaT-catenin in susceptibility to autism spectrum disorder</article-title>
<source/>J Neurodev Disord
          <year>2014</year>
<volume>6</volume>
<issue>1</issue>
<fpage>17</fpage>
<pub-id pub-id-type="doi">10.1186/1866-1955-6-17</pub-id>
<pub-id pub-id-type="pmid">25050139</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baker</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Bass</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Genetic investigation for adults with intellectual disability: opportunities and challenges</article-title>
<source/>Curr Opin Neurol
          <year>2012</year>
<volume>25</volume>
<fpage>150</fpage>
<lpage>158</lpage>
<pub-id pub-id-type="doi">10.1097/WCO.0b013e328351820e</pub-id>
<pub-id pub-id-type="pmid">22357217</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ballif</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Theisen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coppinger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gowans</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Hersh</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Madan-Khetarpal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Tervo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Escobar</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Friedrich</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Mcdonald</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Zackai</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Bejjani</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
</person-group>
<article-title>Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication</article-title>
<source/>Mol Cytogenet
          <year>2008</year>
<volume>1</volume>
<fpage>8</fpage>
<pub-id pub-id-type="doi">10.1186/1755-8166-1-8</pub-id>
<pub-id pub-id-type="pmid">18471269</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Harotunian</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Meador-Woodruff</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Mccullumsmith</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia</article-title>
<source/>Schizophr Res
          <year>2008</year>
<volume>104</volume>
<fpage>108</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1016/j.schres.2008.06.012</pub-id>
<pub-id pub-id-type="pmid">18678470</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianchi</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Bardelli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bussolati</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease</article-title>
<source/>Cell Mol Life Sci
          <year>2014</year>
<volume>71</volume>
<fpage>2001</fpage>
<lpage>2015</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-013-1484-0</pub-id>
<pub-id pub-id-type="pmid">24162932</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brems</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chmara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sahbatou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Denayer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Taniguchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Somers</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Messiaen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>de Schepper</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fryns</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Cools</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Marynen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yoshimura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Legius</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype</article-title>
<source/>Nat Genet
          <year>2007</year>
<volume>39</volume>
<fpage>1120</fpage>
<lpage>1126</lpage>
<pub-id pub-id-type="doi">10.1038/ng2113</pub-id>
<pub-id pub-id-type="pmid">17704776</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burmeister</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mcinnis</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Zollner</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Psychiatric genetics: progress amid controversy</article-title>
<source/>Nat Rev Genet
          <year>2008</year>
<volume>9</volume>
<fpage>527</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1038/nrg2381</pub-id>
<pub-id pub-id-type="pmid">18560438</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carroll</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Moskvina</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Norton</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Peirce</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Georgieva</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dwyer</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grozeva</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Farmer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McGuffin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Corvin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rujescu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Holmans</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha</article-title>
<source/>Mol Psychiatry
          <year>2010</year>
<volume>15</volume>
<issue>11</issue>
<fpage>1101</fpage>
<lpage>1111</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2009.96</pub-id>
<pub-id pub-id-type="pmid">19786960</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casey</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Magalhaes</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Conroy</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Shields</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Abrahams</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bacchelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berney</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bolshakova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cali</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Correia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Corsello</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Coutanche</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>de Jonge</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Duketis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Duque</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Estes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Farrar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Folstein</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Foley</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Freitag</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Glessner</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guter</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hus</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Igliozzi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Klauck</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Kolevzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Le Couteur</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leventhal</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Maestrini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mantoulan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Mcconachie</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mcdougle</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Mcgrath</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mcmahon</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Merikangas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Minopoli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mirza</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Munson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Nygren</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pagnamenta</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Papanikolaou</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Parr</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Parrini</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pickles</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Piven</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Posey</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Poustka</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Poustka</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ragoussis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Roge</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Sequeira</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Soorya</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Sykes</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Stoppioni</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Tancredi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tauber</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Thomson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tsiantis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>van Engeland</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Volkmar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Vorstman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wassink</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>White</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wing</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder</article-title>
<source/>Hum Genet
          <year>2012</year>
<volume>131</volume>
<fpage>565</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-011-1094-6</pub-id>
<pub-id pub-id-type="pmid">21996756</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Witherspoon</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>van Bon</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Vulto-van Silfhout</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Bosco</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Friend</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Buono</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vissers</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Schuurs-Hoeijmakers</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Hoischen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pfundt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Carvill</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lockhart</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Scheffer</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Alberti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pettinato</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tervo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>de Leeuw</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Reijnders</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Torchia</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Peeters</surname>
<given-names>H</given-names>
</name>
<name>
<surname>O’roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Fichera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hehir-Kwa</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Haan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gecz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Refining analyses of copy number variation identifies specific genes associated with developmental delay</article-title>
<source/>Nat Genet
          <year>2014</year>
<volume>46</volume>
<fpage>1063</fpage>
<lpage>1071</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3092</pub-id>
<pub-id pub-id-type="pmid">25217958</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Smiley</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Allan</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Mental ill-health in adults with intellectual disabilities: prevalence and associated factors</article-title>
<source/>Br J Psychiatry
          <year>2007</year>
<volume>190</volume>
<fpage>27</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.bp.106.022483</pub-id>
<pub-id pub-id-type="pmid">17197653</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costello</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bouras</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Assessment of mental health problems in people with intellectual disabilities</article-title>
<source/>Isr J Psychiatry Relat Sci
          <year>2006</year>
<volume>43</volume>
<fpage>241</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="pmid">17338443</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Deciphering Developmental Disorders Study</collab>
</person-group>
<article-title>Prevalence and architecture of de novo mutations in developmental disorders</article-title>
<source/>Nature
          <year>2017</year>
<volume>542</volume>
<fpage>433</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1038/nature21062</pub-id>
<pub-id pub-id-type="pmid">28135719</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denayer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brems</surname>
<given-names>H</given-names>
</name>
<name>
<surname>van Woerden</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Borgesius</surname>
<given-names>NZ</given-names>
</name>
<name>
<surname>Callaerts-Vegh</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yoshimura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Elgersma</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>D’hooge</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Legius</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Balschun</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Spred1 is required for synaptic plasticity and hippocampus-dependent learning</article-title>
<source/>J Neurosci
          <year>2008</year>
<volume>28</volume>
<fpage>14443</fpage>
<lpage>14449</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4698-08.2008</pub-id>
<pub-id pub-id-type="pmid">19118178</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Djurovic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Le Hellard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kahler</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Jonsson</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Agartz</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Steen</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Melle</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Werge</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Andreassen</surname>
<given-names>OA</given-names>
</name>
</person-group>
<article-title>Association of MCTP2 gene variants with schizophrenia in three independent samples of Scandinavian origin (SCOPE)</article-title>
<source/>Psychiatry Res
          <year>2009</year>
<volume>168</volume>
<issue>3</issue>
<fpage>256</fpage>
<lpage>258</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2008.08.007</pub-id>
<pub-id pub-id-type="pmid">19223264</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dolan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mendelsohn</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Pierpont</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Schimmenti</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Hirsch</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>A novel microdeletion/microduplication syndrome of 19p13.13</article-title>
<source/>Genet Med
          <year>2010</year>
<volume>12</volume>
<fpage>503</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3181e59291</pub-id>
<pub-id pub-id-type="pmid">20613546</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elia</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Perin</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Geiger</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Glessner</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>D’arcy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Deberardinis</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Frackelton</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lantieri</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Muganga</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rappaport</surname>
<given-names>EF</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Berrettini</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Devoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>White</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes</article-title>
<source/>Mol Psychiatry
          <year>2010</year>
<volume>15</volume>
<fpage>637</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2009.57</pub-id>
<pub-id pub-id-type="pmid">19546859</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Emerson</surname>
<given-names>E</given-names>
</name>
</person-group>
<source/>Challenging behaviour: analysis and intervention in people with intellectual disabilities
          <year>1995</year>
<publisher-loc>Cambridge</publisher-loc>
<publisher-name>Cambridge University Press</publisher-name>
</element-citation>
</ref>
<ref id="CR20">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furnari</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Jobes</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Nekrasova</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Minden</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>GC</given-names>
</name>
</person-group>
<article-title>Functional deficits in PAK5, PAK6 and PAK5/PAK6 knockout mice</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<fpage>e61321</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0061321</pub-id>
<pub-id pub-id-type="pmid">23593460</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gauthier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Champagne</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lafreniere</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Spiegelman</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Brustein</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lapointe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cote</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Noreau</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hamdan</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Addington</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Rapoport</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Delisi</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Krebs</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Joober</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fathalli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mouaffak</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Haghighi</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Neri</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia</article-title>
<source/>Proc Natl Acad Sci USA
          <year>2010</year>
<volume>107</volume>
<issue>17</issue>
<fpage>7863</fpage>
<lpage>7868</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0906232107</pub-id>
<pub-id pub-id-type="pmid">20385823</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>George</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Jiao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Mitochondrial peptidase IMMP2L mutation causes early onset of age-associated disorders and impairs adult stem cell self-renewal</article-title>
<source/>Aging Cell
          <year>2011</year>
<volume>10</volume>
<fpage>584</fpage>
<lpage>594</lpage>
<pub-id pub-id-type="doi">10.1111/j.1474-9726.2011.00686.x</pub-id>
<pub-id pub-id-type="pmid">21332923</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillentine</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</name>
</person-group>
<article-title>The human clinical phenotypes of altered CHRNA7 copy number</article-title>
<source/>Biochem Pharmacol
          <year>2015</year>
<volume>97</volume>
<issue>4</issue>
<fpage>352</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2015.06.012</pub-id>
<pub-id pub-id-type="pmid">26095975</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gimelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Capra</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Di Rocco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leoni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mirabelli-Badenier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schiaffino</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Fiorio</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cuoco</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tassano</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Interstitial 7q31.1 copy number variations disrupting IMMP2L gene are associated with a wide spectrum of neurodevelopmental disorders</article-title>
<source/>Mol Cytogenet
          <year>2014</year>
<volume>7</volume>
<fpage>54</fpage>
<pub-id pub-id-type="doi">10.1186/s13039-014-0054-y</pub-id>
<pub-id pub-id-type="pmid">25478008</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brkanac</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vu</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Shafer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ferrero</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Silengo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Fichera</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Raskind</surname>
<given-names>WH</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Relative burden of large CNVs on a range of neurodevelopmental phenotypes</article-title>
<source/>PLoS Genet
          <year>2011</year>
<volume>7</volume>
<issue>11</issue>
<fpage>e1002334</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002334</pub-id>
<pub-id pub-id-type="pmid">22102821</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Phenotypic variability and genetic susceptibility to genomic disorders</article-title>
<source/>Hum Mol Genet
          <year>2010</year>
<volume>19</volume>
<fpage>R176</fpage>
<lpage>R187</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddq366</pub-id>
<pub-id pub-id-type="pmid">20807775</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Parikh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Filipink</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>McConnell</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Angle</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Meschino</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Nezarati</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Asamoah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Gowans</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Carmany</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Stockton</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Schnur</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Penney</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>DM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phenotypic heterogeneity of genomic disorders and rare copy-number variants</article-title>
<source/>N Engl J Med
          <year>2012</year>
<volume>367</volume>
<issue>14</issue>
<fpage>1321</fpage>
<lpage>1331</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1200395</pub-id>
<pub-id pub-id-type="pmid">22970919</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glessner</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Korvatska</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Estes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brune</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Bradfield</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Imielinski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Frackelton</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Reichert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Munson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sleiman</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Chiavacci</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Annaiah</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Glaberson</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Flory</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Otieno</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Garris</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Soorya</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Piven</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Anagnostou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Game</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Rudd</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Zurawiecki</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mcdougle</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Posey</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Michaels</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kolevzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Owley</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mcmahon</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Wassink</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Nurnberger</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Coon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Minshew</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Bucan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Autism genome-wide copy number variation reveals ubiquitin and neuronal genes</article-title>
<source/>Nature
          <year>2009</year>
<volume>459</volume>
<fpage>569</fpage>
<lpage>573</lpage>
<pub-id pub-id-type="doi">10.1038/nature07953</pub-id>
<pub-id pub-id-type="pmid">19404257</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grayton</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Missler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Collier</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Altered social behaviours in neurexin 1alpha knockout mice resemble core symptoms in neurodevelopmental disorders</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<issue>6</issue>
<fpage>e67114</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0067114</pub-id>
<pub-id pub-id-type="pmid">23840597</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Green</surname>
<given-names>EK</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Forty</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grozeva</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ripke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chambert</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Genovese</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mccarroll</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>O’donovan</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Craddock</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kirov G</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Copy number variation in bipolar disorder</article-title>
<source/>Mol Psychiatry
          <year>2015</year>
<volume>21</volume>
<issue>1</issue>
<fpage>89</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.174</pub-id>
<pub-id pub-id-type="pmid">25560756</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guilmatre</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dubourg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mosca</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Legallic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Goldenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Drouin-Garraud</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Layet</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rosier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Briault</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bonnet-Brilhault</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Laumonnier</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Odent</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Le Vacon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Joly-Helas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>David</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bendavid</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pinoit</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Impallomeni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Germano</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tortorella</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Di Rosa</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Barthelemy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Andres</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Faivre</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Frebourg</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Saugier Veber</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Campion</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation</article-title>
<source/>Arch Gen Psychiatry
          <year>2009</year>
<volume>66</volume>
<fpage>947</fpage>
<lpage>956</lpage>
<pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2009.80</pub-id>
<pub-id pub-id-type="pmid">19736351</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hahn</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder</article-title>
<source/>Bipolar Disord
          <year>1999</year>
<volume>1</volume>
<issue>2</issue>
<fpage>81</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1034/j.1399-5618.1999.010204.x</pub-id>
<pub-id pub-id-type="pmid">11252663</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hedges</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Hamilton-Nelson</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Sacharow</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Nations</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Beecham</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Kozhekbaeva</surname>
<given-names>ZM</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Cukier</surname>
<given-names>HN</given-names>
</name>
<name>
<surname>Whitehead</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jaworski</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Nathanson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hauser</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Oksenberg</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Cuccaro</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Haines</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Pericak-Vance</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci</article-title>
<source/>Mol Autism
          <year>2012</year>
<volume>3</volume>
<fpage>2</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-2</pub-id>
<pub-id pub-id-type="pmid">22472195</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Wassman</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Baxter</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Hensel</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Twede</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vanzo</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders using an ultra-high resolution chromosomal microarray optimized for neurodevelopmental disorders</article-title>
<source/>Int J Mol Sci
          <year>2016</year>
<volume>17</volume>
<fpage>2070</fpage>
<pub-id pub-id-type="doi">10.3390/ijms17122070</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iafrate</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Feuk</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Listewnik</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Donahoe</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Detection of large-scale variation in the human genome</article-title>
<source/>Nat Genet
          <year>2004</year>
<volume>36</volume>
<fpage>949</fpage>
<lpage>951</lpage>
<pub-id pub-id-type="doi">10.1038/ng1416</pub-id>
<pub-id pub-id-type="pmid">15286789</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarick</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Volckmar</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Putter</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pechlivanis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Dauvermann</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Albayrak</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Scherag</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gilsbach</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cichon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Degenhardt</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nothen</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Schreiber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wichmann</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Jockel</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Heinrich</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tiesler</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Walitza</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sinzig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Freitag</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Herpertz-Dahlmann</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lehmkuhl</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Warnke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Romanos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Reif</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schimmelmann</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Hebebrand</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Scherag</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hinney</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>115</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2012.161</pub-id>
<pub-id pub-id-type="pmid">23164820</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Javitt</surname>
<given-names>DC</given-names>
</name>
</person-group>
<article-title>Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions</article-title>
<source/>Int Rev Neurobiol
          <year>2007</year>
<volume>78</volume>
<fpage>69</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1016/S0074-7742(06)78003-5</pub-id>
<pub-id pub-id-type="pmid">17349858</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hayashi-Takagi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Toyota</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iwamoto</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Gene expression analysis in lymphoblastoid cells as a potential biomarker of bipolar disorder</article-title>
<source/>J Hum Genet
          <year>2011</year>
<volume>56</volume>
<fpage>779</fpage>
<lpage>783</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2011.101</pub-id>
<pub-id pub-id-type="pmid">21866111</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirov</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pocklington</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Holmans</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ruderfer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chambert</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Toncheva</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Georgieva</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grozeva</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fjodorova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wollerton</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Nikolov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Van De Lagemaat</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Bayes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Olason</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Bottcher</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Komiyama</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Choudhary</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stefansson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Stefansson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>O’donovan</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia</article-title>
<source/>Mol Psychiatry
          <year>2012</year>
<volume>17</volume>
<fpage>142</fpage>
<lpage>153</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2011.154</pub-id>
<pub-id pub-id-type="pmid">22083728</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Hurst</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Vargha-Khadem</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>A forkhead-domain gene is mutated in a severe speech and language disorder</article-title>
<source/>Nature
          <year>2001</year>
<volume>413</volume>
<fpage>519</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="doi">10.1038/35097076</pub-id>
<pub-id pub-id-type="pmid">11586359</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamb</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Neill</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Talkowski</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Blumenthal</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Keelean-Fuller</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Pouncey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Mackay-Loder</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Terespolsky</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Rosenbaum</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Vallee</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Moeschler</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Ladda</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features</article-title>
<source/>Hum Mutat
          <year>2012</year>
<volume>33</volume>
<issue>4</issue>
<fpage>728</fpage>
<lpage>740</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22037</pub-id>
<pub-id pub-id-type="pmid">22290657</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ronemus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamrom</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Leotta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kendall</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lakshmi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pai</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Buja</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Krieger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Troge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rodgers</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wigler</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Rare de novo and transmitted copy-number variation in autistic spectrum disorders</article-title>
<source/>Neuron
          <year>2011</year>
<volume>70</volume>
<issue>5</issue>
<fpage>886</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.015</pub-id>
<pub-id pub-id-type="pmid">21658582</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lisi</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Hamosh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Doheny</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Squibb</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Galczynski</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>GH</given-names>
</name>
<name>
<surname>Batista</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>3q29 interstitial microduplication: a new syndrome in a three-generation family</article-title>
<source/>Am J Med Genet A
          <year>2008</year>
<volume>146A</volume>
<fpage>601</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.32190</pub-id>
<pub-id pub-id-type="pmid">18241066</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Brophy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>K</given-names>
</name>
<name>
<surname>James</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Challenging behaviours: prevalence and topographies</article-title>
<source/>J Intellect Disabil Res
          <year>2007</year>
<volume>51</volume>
<fpage>625</fpage>
<lpage>636</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2788.2006.00948.x</pub-id>
<pub-id pub-id-type="pmid">17598876</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowther</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Speevak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Armour</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Goh</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zeesman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nowaczyk</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Morra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nicolson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bikangaga</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Samdup</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zaazou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Siu</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Rajguru</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Goobie</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tarnopolsky</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Prasad</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dick</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Walinga</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reijenga</surname>
<given-names>RG</given-names>
</name>
<name>
<surname>Gazzellone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Stavropoulos</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Mccready</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bassett</surname>
<given-names>AS</given-names>
</name>
</person-group>
<article-title>Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression</article-title>
<source/>Genet Med
          <year>2017</year>
<volume>19</volume>
<fpage>53</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2016.54</pub-id>
<pub-id pub-id-type="pmid">27195815</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Collier</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>A genome-wide association study for quantitative traits in schizophrenia in China</article-title>
<source/>Genes Brain Behav
          <year>2011</year>
<volume>10</volume>
<issue>7</issue>
<fpage>734</fpage>
<lpage>739</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2011.00712.x</pub-id>
<pub-id pub-id-type="pmid">21679298</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maestrini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pagnamenta</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Bacchelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sykes</surname>
<given-names>NH</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Toma</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Barnby</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Winchester</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Scerri</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Minopoli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Reichert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Korvatska</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>De Bildt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Minderaa</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Mulder</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5 loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility</article-title>
<source/>Mol Psychiatry
          <year>2010</year>
<volume>15</volume>
<fpage>954</fpage>
<lpage>968</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2009.34</pub-id>
<pub-id pub-id-type="pmid">19401682</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Noor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Feuk</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Skaug</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shago</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Moessner</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Thiruvahindrapduram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fiebig</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schreiber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ketelaars</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Vos</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Ficicioglu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kirkpatrick</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nicolson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sloman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Summers</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gibbons</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Teebi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chitayat</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Weksberg</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vardy</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Crosbie</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Luscombe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baatjes</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zwaigenbaum</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>Structural variation of chromosomes in autism spectrum disorder</article-title>
<source/>Am J Hum Genet
          <year>2008</year>
<volume>82</volume>
<fpage>477</fpage>
<lpage>488</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2007.12.009</pub-id>
<pub-id pub-id-type="pmid">18252227</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehregan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Najmabadi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kahrizi</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Genetic Studies in Intellectual Disability and Behavioral Impairment</article-title>
<source/>Arch Iran Med
          <year>2016</year>
<volume>19</volume>
<fpage>363</fpage>
<lpage>375</lpage>
<pub-id pub-id-type="pmid">27179170</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moessner</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Skaug</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zwaigenbaum</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>Contribution of SHANK3 mutations to autism spectrum disorder</article-title>
<source/>Am J Hum Genet
          <year>2007</year>
<volume>81</volume>
<issue>6</issue>
<fpage>1289</fpage>
<lpage>1297</lpage>
<pub-id pub-id-type="doi">10.1086/522590</pub-id>
<pub-id pub-id-type="pmid">17999366</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno-De-Luca</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Challman</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Moreno-De-Luca</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Ledbetter</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence</article-title>
<source/>Lancet Neurol
          <year>2013</year>
<volume>12</volume>
<fpage>406</fpage>
<lpage>414</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(13)70011-5</pub-id>
<pub-id pub-id-type="pmid">23518333</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bourke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jablensky</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study</article-title>
<source/>Br J Psychiatry
          <year>2008</year>
<volume>193</volume>
<fpage>364</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="doi">10.1192/bjp.bp.107.044461</pub-id>
<pub-id pub-id-type="pmid">18978313</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myles-Worsley</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tiobech</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Browning</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Korn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gentile</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Melhem</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Byerley</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Middleton</surname>
<given-names>FA</given-names>
</name>
</person-group>
<article-title>Deletion at the SLC1A1 glutamate transporter gene co-segregates with schizophrenia and bipolar schizoaffective disorder in a 5-generation family</article-title>
<source/>Am J Med Genet B
          <year>2013</year>
<volume>162B</volume>
<fpage>87</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32125</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nesbitt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bhoj</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>McDonald Gibson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Denenberg</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sarmady</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tischler</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dubbs</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zackai</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Santani</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Exome sequencing expands the mechanism of SOX5-associated intellectual disability: a case presentation with review of sox-related disorders</article-title>
<source/>Am J Med Genet A
          <year>2015</year>
<volume>167A</volume>
<issue>11</issue>
<fpage>2548</fpage>
<lpage>2554</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37221</pub-id>
<pub-id pub-id-type="pmid">26111154</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dupuis</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mittal</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Stockley</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Mendoza-Londono</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Stavropoulos</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>15q11.2 duplication encompassing only the UBE3A gene is associated with developmental delay and neuropsychiatric phenotypes</article-title>
<source/>Hum Mutat
          <year>2015</year>
<volume>36</volume>
<issue>7</issue>
<fpage>689</fpage>
<lpage>693</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22800</pub-id>
<pub-id pub-id-type="pmid">25884337</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Cohen-Woods</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moghimi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rucker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fennell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thiruvahindrapuram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Degagne</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Parikh</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Muglia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Forte</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>McGuffin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Farmer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Strauss</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>JB</given-names>
</name>
</person-group>
<article-title>Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2014</year>
<volume>165B</volume>
<issue>4</issue>
<fpage>303</fpage>
<lpage>313</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32232</pub-id>
<pub-id pub-id-type="pmid">24700553</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ophoff</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Escamilla</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Service</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Spesny</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Meshi</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Molina</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fournier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gallegos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mathews</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Neylan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Batki</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>S</given-names>
</name>
<name>
<surname>De Mille</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Leon</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Reus</surname>
<given-names>VI</given-names>
</name>
<name>
<surname>Sandkuijl</surname>
<given-names>LA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate</article-title>
<source/>Am J Hum Genet
          <year>2002</year>
<volume>71</volume>
<issue>3</issue>
<fpage>565</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="doi">10.1086/342291</pub-id>
<pub-id pub-id-type="pmid">12119601</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orellana</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rosello</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Monfort</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mayo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oltra</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Pure duplication of 19p13.3 in three members of a family with intellectual disability and literature review. Definition of a new microduplication syndrome</article-title>
<source/>Am J Med Genet A
          <year>2015</year>
<volume>167</volume>
<fpage>1614</fpage>
<lpage>1620</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37046</pub-id>
<pub-id pub-id-type="pmid">25858326</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karakoc</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Stanaway</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Vernot</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Malig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Reilly</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Akey</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Borenstein</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rieder</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Nickerson</surname>
<given-names>DA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<issue>7397</issue>
<fpage>246</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1038/nature10989</pub-id>
<pub-id pub-id-type="pmid">22495309</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pagnamenta</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Bacchelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>De Jonge</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Mirza</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Scerri</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Minopoli</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chiocchetti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ludwig</surname>
<given-names>KU</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Paracchini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lowy</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Harold</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Klauck</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Poustka</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Houben</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Staal</surname>
<given-names>WG</given-names>
</name>
<name>
<surname>Ophoff</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>O’donovan</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nothen</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Schulte-Korne</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Deloukas</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ragoussis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Maestrini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia</article-title>
<source/>Biol Psychiatry
          <year>2010</year>
<volume>68</volume>
<fpage>320</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2010.02.002</pub-id>
<pub-id pub-id-type="pmid">20346443</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pantano</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Armengol</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Villatoro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Estivill</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>ProSeeK: a web server for MLPA probe design</article-title>
<source/>BMC Genom
          <year>2008</year>
<volume>9</volume>
<fpage>573</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2164-9-573</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pasmant</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sabbagh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Masliah-Planchon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jolly</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Goussard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ballerini</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cartault</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Barbarot</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Landman-Parker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Soufir</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Parfait</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Vidaud</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wolkenstein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vidaud</surname>
<given-names>D</given-names>
</name>
<name>
<surname>France</surname>
<given-names>RN</given-names>
</name>
</person-group>
<article-title>SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype</article-title>
<source/>J Med Genet
          <year>2009</year>
<volume>46</volume>
<issue>7</issue>
<fpage>425</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2008.065243</pub-id>
<pub-id pub-id-type="pmid">19366998</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pagnamenta</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Conroy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Magalhaes</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Correia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Abrahams</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bacchelli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Baird</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Battaglia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berney</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bolshakova</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bolte</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Bourgeron</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brian</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bryson</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Carson</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Casallo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Cochrane</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Corsello</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Crossett</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cytrynbaum</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>de Jonge</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Delorme</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Drmic</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Duketis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Duque</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Estes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Farrar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Folstein</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Freitag</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Glessner</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guter</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Howe</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hus</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Igliozzi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Klauck</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Kolevzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Korvatska</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kustanovich</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lajonchere</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Laskawiec</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Le Couteur</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leventhal</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>XQ</given-names>
</name>
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lotspeich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Maestrini</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mahoney</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Mantoulan</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Mcconachie</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mcdougle</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Mcgrath</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mcmahon</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Merikangas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Migita</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Minshew</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Mirza</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Munson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Noakes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Noor</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nygren</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Papanikolaou</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Parr</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Parrini</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Paton</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pickles</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pilorge</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional impact of global rare copy number variation in autism spectrum disorders</article-title>
<source/>Nature
          <year>2010</year>
<volume>466</volume>
<fpage>368</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="doi">10.1038/nature09146</pub-id>
<pub-id pub-id-type="pmid">20531469</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plummer</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Levitt</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>The genetic intersection of neurodevelopmental disorders and shared medical comorbidities—relations that translate from bench to bedside</article-title>
<source/>Front Psychiatry
          <year>2016</year>
<volume>7</volume>
<fpage>142</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2016.00142</pub-id>
<pub-id pub-id-type="pmid">27597832</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porton</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Askland</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Serra</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Gesmonde</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rudnick</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Kao</surname>
<given-names>HT</given-names>
</name>
</person-group>
<article-title>Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder</article-title>
<source/>Transl Psychiatry
          <year>2013</year>
<volume>3</volume>
<fpage>e259</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2013.35</pub-id>
<pub-id pub-id-type="pmid">23695234</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Posey</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>James</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Bainbridge</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dhar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wiszniewski</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Akdemir</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Gambin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Person</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Walkiewicz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>VR</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Muzny</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Boerwinkle</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Plon</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Molecular diagnostic experience of whole-exome sequencing in adult patients</article-title>
<source/>Genet Med
          <year>2016</year>
<volume>18</volume>
<fpage>678</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2015.142</pub-id>
<pub-id pub-id-type="pmid">26633545</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prasad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Thiruvahindrapuram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rickaby</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Hatchwell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Eis</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>A discovery resource of rare copy number variations in individuals with autism spectrum disorder</article-title>
<source/>G3 (Bethesda)
          <year>2012</year>
<volume>2</volume>
<issue>12</issue>
<fpage>1665</fpage>
<lpage>1685</lpage>
<pub-id pub-id-type="doi">10.1534/g3.112.004689</pub-id>
<pub-id pub-id-type="pmid">23275889</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos-Quiroga</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sanchez-Mora</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Casas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garcia-Martinez</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nogueira</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Corrales</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Palomar</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Vidal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Coll-Tane</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bayes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cormand</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ribases</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Genome-wide copy number variation analysis in adult attention-deficit and hyperactivity disorder</article-title>
<source/>J Psychiatr Res
          <year>2014</year>
<volume>49</volume>
<fpage>60</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2013.10.022</pub-id>
<pub-id pub-id-type="pmid">24269040</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ballif</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Torchia</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Sahoo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ravnan</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lamb</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bejjani</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
</person-group>
<article-title>Copy number variations associated with autism spectrum disorders contribute to a spectrum of neurodevelopmental disorders</article-title>
<source/>Genet Med
          <year>2010</year>
<volume>12</volume>
<issue>11</issue>
<fpage>694</fpage>
<lpage>702</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3181f0c5f3</pub-id>
<pub-id pub-id-type="pmid">20808228</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</name>
</person-group>
<article-title>Nicotinic acetylcholine receptors in human genetic disease</article-title>
<source/>Genet Med
          <year>2014</year>
<volume>16</volume>
<issue>9</issue>
<fpage>649</fpage>
<lpage>656</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2014.9</pub-id>
<pub-id pub-id-type="pmid">24556925</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Boone</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Sampath</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Shchelochkov</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>HP</given-names>
</name>
<name>
<surname>Phalen</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Tartaglia</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Parsley</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grayson</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Scheuerle</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Luzzi</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>PA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions</article-title>
<source/>Eur J Hum Genet
          <year>2012</year>
<volume>20</volume>
<issue>12</issue>
<fpage>1240</fpage>
<lpage>1247</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2012.95</pub-id>
<pub-id pub-id-type="pmid">22617343</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sebat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lakshmi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Troge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lundin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Maner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Massa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Navin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lucito</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Healy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hicks</surname>
<given-names>J</given-names>
</name>
<name>
<surname>YE</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Reiner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gilliam</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Trask</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zetterberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wigler</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Large-scale copy number polymorphism in the human genome</article-title>
<source/>Science
          <year>2004</year>
<volume>305</volume>
<fpage>525</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="doi">10.1126/science.1098918</pub-id>
<pub-id pub-id-type="pmid">15273396</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spencer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mikhail</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vijzelaar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zackai</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Feret</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Meyn</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Shugar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bellus</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kocsis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kivirikko</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Poyhonen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Messiaen</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Identification of SPRED1 deletions using RT-PCR, multiplex ligation-dependent probe amplification and quantitative PCR</article-title>
<source/>Am J Med Genet A
          <year>2011</year>
<volume>155A</volume>
<fpage>1352</fpage>
<lpage>1359</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.33894</pub-id>
<pub-id pub-id-type="pmid">21548021</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stein</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nesse</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Classification systems in psychiatry: diagnosis and global mental health in the era of DSM-5 and ICD-11</article-title>
<source/>Curr Opin Psychiatry
          <year>2013</year>
<volume>26</volume>
<fpage>493</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="doi">10.1097/YCO.0b013e3283642dfd</pub-id>
<pub-id pub-id-type="pmid">23867662</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swaminathan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Inlow</surname>
<given-names>M</given-names>
</name>
<name>
<surname>West</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Faber</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Foroud</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mayeux</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Saykin</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Analysis of copy number variation in Alzheimer’s disease: the NIALOAD/NCRAD Family Study</article-title>
<source/>Curr Alzheimer Res
          <year>2012</year>
<volume>9</volume>
<fpage>801</fpage>
<lpage>814</lpage>
<pub-id pub-id-type="doi">10.2174/156720512802455331</pub-id>
<pub-id pub-id-type="pmid">22486522</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Okano</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Takagi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Saiga</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakayama</surname>
<given-names>KI</given-names>
</name>
<name>
<surname>Kashima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Setou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>OKANO</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Fbxo45, a novel ubiquitin ligase, regulates synaptic activity</article-title>
<source/>J Biol Chem
          <year>2010</year>
<volume>285</volume>
<fpage>3840</fpage>
<lpage>3849</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M109.046284</pub-id>
<pub-id pub-id-type="pmid">19996097</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Jirikowic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Springer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mcgavran</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lunt</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Swisshelm</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>High prevalence of array comparative genomic hybridization abnormalities in adults with unexplained intellectual disability</article-title>
<source/>Genet Med
          <year>2010</year>
<volume>12</volume>
<fpage>32</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1097/GIM.0b013e3181c83de0</pub-id>
<pub-id pub-id-type="pmid">20009761</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van TebartzElst</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fangmeier</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Endres</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>GT</given-names>
</name>
<name>
<surname>Nickel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hennig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Biscaldi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Riedel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Perlov</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Disturbed cingulate glutamate metabolism in adults with high-functioning autism spectrum disorder: evidence in support of the excitatory/inhibitory imbalance hypothesis</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>1314</fpage>
<lpage>1325</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.62</pub-id>
<pub-id pub-id-type="pmid">25048006</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinas-Jornet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Esteba-Castillo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gabau</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ribas-Vidal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Baena</surname>
<given-names>N</given-names>
</name>
<name>
<surname>San</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Coll</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Novell</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guitart</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>A common cognitive, psychiatric, and dysmorphic phenotype in carriers of NRXN1 deletion</article-title>
<source/>Mol Genet Genomic Med
          <year>2014</year>
<volume>2</volume>
<fpage>512</fpage>
<lpage>521</lpage>
<pub-id pub-id-type="doi">10.1002/mgg3.105</pub-id>
<pub-id pub-id-type="pmid">25614873</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waga</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ondo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fukumura-Kato</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kohsaka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Uchino</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Novel variants of the SHANK3 gene in Japanese autistic patients with severe delayed speech development</article-title>
<source/>Psychiatr Genet
          <year>2011</year>
<volume>21</volume>
<issue>4</issue>
<fpage>208</fpage>
<lpage>211</lpage>
<pub-id pub-id-type="doi">10.1097/YPG.0b013e328341e069</pub-id>
<pub-id pub-id-type="pmid">21378602</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walss-Bass</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Soto-Bernardini</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Johnson-Pais</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Leach</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Ontiveros</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nicolini</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mendoza</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jerez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dassori</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chavarria-Siles</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Escamilla</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Raventos</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Methionine sulfoxide reductase: a novel schizophrenia candidate gene</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2009</year>
<volume>150B</volume>
<issue>2</issue>
<fpage>219</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30791</pub-id>
<pub-id pub-id-type="pmid">18506707</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Koide</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kunimoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yoshimi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kushima</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Banno</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kawano</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Takasaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mouri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aleksic</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iidaka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Inada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia</article-title>
<source/>Schizophr Res
          <year>2014</year>
<volume>157</volume>
<fpage>149</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="doi">10.1016/j.schres.2014.04.032</pub-id>
<pub-id pub-id-type="pmid">24878430</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bucan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Glessner</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Abrahams</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Salyakina</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Imielinski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bradfield</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Sleiman</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Frackelton</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Chiavacci</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sakurai</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rappaport</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lajonchere</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Munson</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Estes</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Common genetic variants on 5p14.1 associate with autism spectrum disorders</article-title>
<source/>Nature
          <year>2009</year>
<volume>459</volume>
<issue>7246</issue>
<fpage>528</fpage>
<lpage>533</lpage>
<pub-id pub-id-type="doi">10.1038/nature07999</pub-id>
<pub-id pub-id-type="pmid">19404256</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Arking</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Chakravarti</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A genome-wide linkage and association scan reveals novel loci for autism</article-title>
<source/>Nature
          <year>2009</year>
<volume>461</volume>
<issue>7265</issue>
<fpage>802</fpage>
<lpage>808</lpage>
<pub-id pub-id-type="doi">10.1038/nature08490</pub-id>
<pub-id pub-id-type="pmid">19812673</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willatt</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Barber</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cabanas</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Donnai</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fitzpatrick</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Maher</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Parnau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pindar</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ramsay</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shaw-Smith</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sistermans</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Tettenborn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Trump</surname>
<given-names>D</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>FL</given-names>
</name>
</person-group>
<article-title>3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome</article-title>
<source/>Am J Hum Genet
          <year>2005</year>
<volume>77</volume>
<fpage>154</fpage>
<lpage>160</lpage>
<pub-id pub-id-type="doi">10.1086/431653</pub-id>
<pub-id pub-id-type="pmid">15918153</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wisniowiecka-Kowalnik</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nesteruk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Savage</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Amato</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Browning</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Haun</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Duda</surname>
<given-names>AW</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>Cheung</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental delay, and speech delay</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2010</year>
<volume>153B</volume>
<issue>5</issue>
<fpage>983</fpage>
<lpage>993</lpage>
<pub-id pub-id-type="pmid">20162629</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolfe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Strydom</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Morrogh</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cutajar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Eyeoyibo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hassiotis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mccarthy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Paschos</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Perumal</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Read</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sharif</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thirulokachandran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thygesen</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Patch</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ogilvie</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Flinter</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mcquillin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>BASS</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders</article-title>
<source/>Eur J Hum Genet
          <year>2016</year>
<volume>25</volume>
<fpage>66</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2016.107</pub-id>
<pub-id pub-id-type="pmid">27650969</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Roos</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>van Rensburg</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Gogos</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Karayiorgou</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Strong association of de novo copy number mutations with sporadic schizophrenia</article-title>
<source/>Nat Genet
          <year>2008</year>
<volume>40</volume>
<fpage>880</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="doi">10.1038/ng.162</pub-id>
<pub-id pub-id-type="pmid">18511947</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>